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ABSTRACT OF THE DISSERTATION 
Strategies for Increasing the Applicability of Biological Network Inference 
by 
Ezekiel John Maier 
Doctor of Philosophy in Computer Science 
Washington University in St. Louis, 2015 
Professor Michael Brent, Chair 
 
The manipulation of cellular state has many promising applications, including stem cell biology 
and regenerative medicine, biofuel production, and stress resistant crop development. The 
construction of interaction maps promises to enhance our ability to engineer cellular behavior. 
Within the last 15 years, many methods have been developed to infer the structure of the gene 
regulatory interaction map from gene abundance snapshots provided by high-throughput 
experimental data. However, relatively little research has focused on using gene regulatory 
network models for the prediction and manipulation of cellular behavior. This dissertation 
examines and applies strategies to utilize the predictive power of gene network models to guide 
experimentation and engineering efforts. First, we developed methods to improve gene network 
models by integrating interaction evidence sources, in order to utilize the full predictive power of 
the models. Next, we explored the power of networks models to guide experimental efforts 
through inference and analysis of a regulatory network in the pathogenic fungus Cryptococcus 
neoformans. Finally, we develop a novel, network-guided algorithm to select genetic 
interventions for engineering transcriptional state. We apply this method to select intervention 
strains for improving biofuel production in a mixed glucose-xylose environment. The 
contributions in this dissertation provide the first thorough examination, systematic application, 
and quantitative evaluation of the utilization of network models for guiding cellular engineering. 
1 
 
Chapter 1: Introduction 
A paradigm shift has occurred in biological research in the past 15 years, from the study 
of only a small number of genes at a time, to the system wide study of molecular interactions in a 
cell. This rapidly expanding field of Systems Biology focuses on understanding cellular 
processes by mapping and modeling the cellular interactome. The construction of interaction 
maps promises to enable us to predict and manipulate cellular behavior, which will have many 
important applications such as human disease treatment and stress resistant crop development. 
Determining the transcriptional regulatory relationships between transcription factors and their 
target genes, which control the abundance of each gene product, is a key step towards gaining a 
complete view of the cell’s interactome. 
Gene expression profiles, or RNA profiles, yield quantitative data on the transcriptional state of a 
cell in a specific condition and time. Recent advances in high throughput methods for characterizing gene 
expression, such as DNA microarrays and RNA-seq, have made it easier, cheaper, and faster to obtain 
gene expression profiles. These experimental advances have spurred the development of computational 
methods that use gene expression profiles to infer a model of the global transcriptional regulatory 
network. In the last decade many algorithms have been developed to infer the structure of gene 
regulatory networks from gene expression profiles. A common approach taken by these 
algorithms to learning transcriptional regulatory network structure is to find, for each gene ga, 
another gene or group of genes encoding transcription factors whose RNA levels best explains 
ga's RNA level. As more sophisticated methods have been developed, the structural accuracy of 
inference algorithms has dramatically improved. Despite the advances in structural network 
recovery, transcriptional network inference has not met the need to generate predictive models 
that aid in experimental design and cellular engineering efforts. 
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Understanding, predicting, and manipulating complex cellular states requires structural 
and functional models of the cell. Most gene regulatory network inference algorithms provide a 
structural map of transcriptional interactions and an underlying mathematical model that can 
predict transcriptional results of genetic interventions. However, research using network models 
generally focuses on interpretation of the network structure, and neglects to use networks models 
to predict expression and physiological phenotypes. This dissertation begins to bridge the gap 
between inferring gene regulatory network models and utilizing the predictive power of the 
models to guide further research. First, we integrate the processes of inferring gene regulatory 
network models and de novo inference of transcription factor binding specificity to generate a 
causative, as opposed to a correlative network model, while exploring the ability of network 
models to aid in identifying transcription factor binding sites. We then explore the ability of 
network models to guide research by taking an active learning approach, which iterates between 
network inference and physiological phenotype prediction. Finally, we demonstrate the ability of 
causative regulatory network models to guide a cellular engineering effort by generating strains 
with regulatory interventions selected by simulated intervention expression predictions.  
In chapter 2, we investigate strategies to infer more causative network models consisting 
of interactions that are supported by direct and functional evidence. Causative network models 
allow for better network-based expression and phenotype prediction than network models that 
rely solely on correlative analysis because they eliminate the effects of indirect regulatory 
interactions. To respond to the need for more causative network models for prediction 
applications, we develop a method to integrate the processes of network inference from gene 
expression profiles and de novo TF binding motif discovery. Through iteration, we are able to 
identify novel TF binding motifs and integrate them into the network to enrich the network for 
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direct causative interactions. We evaluate this approach by applying it to the inference of the 
Saccharomyces cerevisiae and Cryptococcus neoformans networks and TF binding motifs. In 
Cryptococcus neoformans, we identify 18 TF binding motifs, 15 of which are novel.  
In chapter 3, we map and model a regulatory network in Cryptococcus neoformans 
controlling the size of the fungal pathogen’s capsule by joining the processes of computational 
modeling and experimentation. In this project, we explore the utility of network models as 
guidance for selecting costly experiments, by iterating between inferring the transcriptional 
regulatory network, using the network to make physiological phenotype predictions and selecting 
the next expression profiles to acquire. During this process we identify 18 novel regulators 
controlling the size of the polysaccharide capsule, which increased the number of known capsule 
size regulators to 27. With the finalized network map, we are able to identify many regulators 
controlling the enzymes responsible for the creation of capsule sugars.  
Finally, in chapter 4, we fully evaluate the predictive power of causative network models 
by using a network model to guide transcriptome engineering. In this work, we build on our 
successes and knowledge gained in constructing and utilizing causative networks for prediction 
to develop the first validated, network-guided algorithm to select interventions for engineering 
transcriptional state. The NetSurgeon algorithm simulates regulator deletion and overexpression 
interventions on a causative network model, and selects the interventions that are predicted to 
force the expression state toward a goal state. We apply this algorithm to select intervention 
strains yielding promising results for improved biofuel production in a mixed glucose-xylose 
environment which have an enhanced fermentative transcriptional state in glucose-limited 
conditions. In addition, our generated intervention strains included strains with 120% higher 
xylose import rates and 31% increased ethanol production rates. The transcriptional and 
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metabolic enhanced fermentative state of these strains demonstrates the power of using causative 
networks models to guide cellular engineering. 
1.1 Contributions 
1. Development of methods to remove indirect regulatory network edges by inferring 
and integrating transcription factor binding specificity. We present a method for de 
novo transcription factor binding motif inference by utilizing regulatory network structure 
and DNA-binding domain similarity. This contribution is presented in chapter 2. 
2. Inference and analysis of the Cryptococcus capsule regulatory network. We take a 
network-driven iterative approach to infer the network that regulates the production and 
thickness of the polysaccharide capsule of Cryptococcus neoformans, the key virulence 
factor of this pathogenic fungus. This contribution is presented in chapter 3. 
3. Development of NetSurgeon, a novel algorithm for regulatory intervention selection. 
We present an algorithm which aids in the rational manipulation of transcriptomes by 
utilizing a regulatory network to identify overexpression and deletion interventions that 
will force the expression state towards a desired goal state. This contribution is presented 
in chapter 4. 
4. Application of NetSurgeon to engineer Saccharomyces cerevisiae strains. We apply 
NetSurgeon to Saccharomyces cerevisiae biofuel production, by selecting and generating 
intervention strains that promote a fermentative transcriptional state in the presence of 
xylose, an alternative carbon source. This contribution is presented in chapter 4. 
 
  
5 
 
Chapter 2: 
Integration of Transcription Factor Binding 
Specificity 
2.1 Abstract 
Gene network models are vital to understanding how genes interact to regulate the 
transcriptional response to external stimuli. Within the last 15 years, much research has focused 
on inferring the structure of the gene regulatory networks. There have been two distinct 
approaches to this problem: regulatory network model inference from gene expression profiles 
and regulatory network model construction from identified transcription factor binding sites. In 
this work we have developed methods to integrate these approaches. We show that the gene 
regulatory network model structure can be improved by integrating known or inferred 
transcription factor binding specificities. We also demonstrate methods to improve DNA binding 
specificity inference, and we apply these methods to infer PWMs for C. neoformans transcription 
factors. Our application of these methods increased the number C. neoformans transcription 
factors with known binding specificities from 2 to 18. 
2.2 Background 
2.2.1 DNA Motif Discovery 
One approach for constructing gene regulatory network models is to utilize the DNA 
binding specificities of transcription factors (TFs) to identify binding sites in the promoters of 
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target genes. The binding specificity of a TF can be represented as a position weight matrix 
(PWM), which gives the probability of observing nucleotide j in position w of bound sequences. 
A score for an aligned substring can be calculated as the sum of log-likelihoods at each position 
of the alignment. By scoring substrings of DNA, PWMs can be used to identify sites with a 
greater potential for TF binding and transcriptional regulation. 
There is a rich literature of computational methods for de novo DNA binding motif 
discovery. These methods identify similar DNA motifs within multiple input DNA sequences. 
DNA binding motif discovery methods are often used to infer TF binding specificity models by 
searching through TF bound promoters to identify enriched motifs. There are two broad 
approaches taken by these methods: mixture-modeling and discrimination (Lee et al. 2013). 
Many mixture model based methods use either expectation maximization (example: MEME, 
Bailey et al. 2006), or Gibbs Sampling (example: BioProspector, Liu et al. 2001) to identify TF 
binding sites and estimate PWMs. Discriminatory approaches, including CMF (Lee et al. 2013) 
and FIRE (Elemento et al. 2007), identify motifs that maximally separate a set of bound and 
unbound sequences. The identification of TF binding sites has been a major area of biological 
research and many current algorithms have been successfully demonstrated in lower model 
organisms (Das et al. 2007). However, computational motif discovery remains a challenging 
problem, beset with high false positive rates, and in need of additional prior knowledge to aid 
motif discovery (Simcha et al. 2012). 
In recent years, the identification of transcription factor binding sites (TFBS) has 
improved dramatically through in vivo (ChIP) and in vitro (e.g. protein-binding microarray, 
PBM) methods for measuring protein DNA binding (Valouev et al. 2008 & Berger et al. 2009). 
There have been several large studies using these experimental techniques (Harbison et al. 2004; 
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Lee et al. 2002; Nègre et al. 2011; Badis et al. 2009; ENCODE Project Consortium 2012; 
Weirauch et al. 2014) and PWMs inferred in these studies are available in many public databases 
(Spivak & Stormo 2012; Shazman et al. 2013; Bryne et al. 2008; Matys et al. 2003).  
The large-scale availability of TF binding specificity models has allowed researchers to 
identify links between protein homology and DNA binding specificity. Specifically, with the 
advent of large collections of inferred PWMs, several groups have conclusively shown that TFs 
with similar DNA binding domains (DBDs) also have similar TF binding specificities (Weirauch 
et al. 2014; Jolma et al. 2013). This observation was used by the Hughes group in their Cis-BP 
database of TF binding specificities (Weirauch et al. 2014). In the Cis-BP database they infer 
binding specificities for TFs without experimentally derived PWMs by assigning the PWM of 
the TF with the most similar DBD. Several other approaches have used machine learning 
techniques, including K-Nearest-Neighbors and Random Forests, to predict binding specificities 
for TFs from the PWMs of homologous TFs (Gupta et al. 2014; Christensen et al. 2012). 
There has been a rapid rise in the number of TFs with known or inferred binding 
specificities. However, there is not a reliable binding specificity model for most non-model 
organism TFs (Weirauch et al. 2014). Even for human TFs, only 974 of the 1,734 putative TFs 
have a binding specificity model that has been experimentally derived or inferred (Weirauch et 
al. 2014). Therefore, to avoid costly experimentation, additional research is required to improve 
computational motif inference. 
2.2.2 Gene Expression-Only Approaches for Inferring Gene Regulatory 
Networks 
Another approach for constructing gene regulatory network models involves inferring the 
models from gene expression profiles. Advances in high throughput methods for characterizing 
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gene expression have spurred the development of computational methods aimed at inferring the 
structure and kinetics of regulatory networks (Gardner & Faith 2005). These algorithms attempt 
to learn a network that best explains the measurements of all RNA transcripts in cells grown 
under various experimental conditions. 
To evaluate the structural accuracy of an inferred network model, predicted interactions 
are ranked by confidence scores and compared to the true network structure, which is typically 
defined by ChIP-seq and ChIP-chip experiments that identify transcription factor binding sites on 
the promoter of target genes. A series of predicted networks is constructed by going down the list 
of predicted interactions, from most confident to least confident, and adding one interaction at a 
time to the previous network in the series. Each of these networks is evaluated using precision 
and recall statistics, which measure the accuracy and completeness of the inferred networks, 
respectively. 
The most accurate and most recent expression only network inference algorithm is 
NetProphet (Haynes et al. 2013). This algorithm achieves superior accuracy by analyzing the 
expression profiles in two ways, then combining the results into a single model. First, 
NetProphet uses a LASSO solver to infer a regression-based regulatory network. In addition, 
NetProphet constructs a perturbation-based regulatory network by inferring interactions between 
experimentally perturbed regulators and the genes that are significantly affected by each 
perturbation. These two regulatory networks are weighted and combined. This approach has been 
demonstrated to be the best expression-only method for inferring the gene regulatory network 
structure of S. cerevisiae. 
Although expression-only methods have improved dramatically, these algorithms are 
only able to infer a portion of the S. cerevisiae regulatory network with convincing accuracy. 
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Several challenges must be addressed in order to improve accuracy. First, expression-only 
inference methods rely upon co-expression of transcription factors and target genes to recover 
interactions. This reliance on co-expression allows these methods to recover many direct 
functional interactions; however, these methods can also incorrectly infer interactions between 
TFs and target genes that are indirectly co-expressed. A second challenge faced by these 
inference methods is modeling combinatorial gene regulation. Instead of direct transcriptional 
control by a single regulator, the transcription of many targets is controlled by the combined 
effects of several regulators. Combinatorial regulation makes it more difficult to infer true 
regulators by obscuring the relationship between regulator and target RNA concentration. 
  
2.3 Related Work 
Network inference approaches which utilize both expression-based inference and 
transcription factor binding site knowledge are strengthened by prioritizing interactions that the 
two approaches support. Support from each approach provides physical evidence of protein 
DNA binding and functional evidence of a regulatory effect. There are several notable methods 
which utilize this integrative network inference approach. 
In recent work, Marbach et al. used an integrative approach to construct a gene regulatory 
network for D. melanogaster (Marbach et al. 2012). They constructed one network from 
interactions supported by ChIP experiments and TF binding motifs. They then constructed a 
second network from functional evidence by correlating expression patterns of transcription 
factors and target genes. Finally, they averaged the interaction scores from the functional and 
physical networks. Interestingly, although the physical and functional networks show little 
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overlap in their most confident interactions, Marbach et al. found that averaging the two 
evidence sources generated a more accurate network.  
A few methods have been proposed to integrate physical evidence directly into the 
regression approach for inferring gene regulatory networks. One notable example is the TILAR 
method, which uses knowledge of transcription factor binding sites to modify the L1 LASSO 
penalty (Hecker, Goertsches, Engelmann, Thiesen, & Guthke, 2009). This modification 
influences the order of regulator selection for each gene by biasing the selection toward 
regulators that are supported by prior knowledge.  
Integrative network inference methods are often able infer regulatory networks with more 
accuracy than expression-only inference methods (De Smet et al. 2010). Moreover, the 
integration of binding data helps to solve some of the common problems encountered by 
expression-only inference methods, as binding data can be used to filter-out indirect regulatory 
interactions. Although integrative approaches are extremely promising, current approaches are 
stifled by their reliance upon prior knowledge of TF binding specificity. Due to the 
incompleteness of TF binding specificity knowledge, even for well studied organisms, 
integrative approaches must be able to infer novel TF binding specificities to reach their full 
potential.  
2.4 Approach 
In this work we investigated strategies to generate more accurate gene regulatory network 
models by integrating the processes of expression-only network inference and de novo DNA 
binding motif discovery. Our approach to integrating these processes started by using NetProphet 
(Haynes et al. 2013) to infer a gene regulatory network model from gene expression data (Fig 2.1 
Top). Next, we inferred the DNA binding specificity of each TF by searching for enriched motifs 
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in the promoters of high confidence targets of the each TF (Fig 2.1 Middle). Finally, we 
integrated inferred DNA binding specificities into the gene regulatory network model by 
combining the functional network interaction scores assigned by NetProphet with the physical 
network interaction scores assigned by scanning the PWMs over all promoter sequences (Fig 2.1 
Bottom). 
 
Figure 2.1. Integrated regulatory network and DNA binding specificity inference. Top: Inference of a gene 
regulatory network model from gene expression profiles. Middle: Inference of DNA binding specificity of each TF 
from the promoter sequences of the predicted targets of the TF. Bottom: Modification of interaction confidence 
scores in the network model using inferred DNA binding specificity. 
2.5 Results 
2.5.1 Integration of known TF DNA binding specificities improves structural 
accuracy  
To assess the improvements to the gene regulatory network model by integrating TF 
binding specificities, we constructed an integrated functional and physical network of S. 
cerevisiae. The integrated network model was constructed by combining the original published 
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NetProphet network model produced by Haynes et al. (Haynes et al. 2012) with a regulatory 
network constructed by scanning all known S. cerevisiae PWMs (Spivak & Stormo, 2012) over 
all promoter sequences. Finally, the integrated NetProphet+PWM network model was 
constructed by computing the geometric mean of scores in the functional and physical networks. 
We evaluated the structural accuracy of the NetProphet+PWM network and compared it 
to the accuracy of the separate NetProphet and PWM networks. The gold standard was a network 
of over 29,000 chromatin immunoprecipitation (ChIP) implicated interactions (Abdulrehman, et 
al. 2010; Balaji et al. 2006; Harbison et al. 2004; Lee et al. 2002). We plotted a precision-recall 
curve for each network (Fig 2.2). 
 
Figure 2.2. Integration of DNA binding specificity improves network structure. Precision-Recall plot showing the 
recovery of ChIP-supported interactions by the NetProphet inferred network (purple), binding potential network 
constructed using ScerTF binding models (Yellow), and a network constructed by combining NetProphet and the 
binding potential network (green). Random ChIP recovery is shown by the gray dotted line. 
We examined the ChIP support of the most confident predicted interactions of each 
network by focusing on the initial 5% of the recall space. Throughout this recall space the 
NetProphet+PWM (Fig 2.2, Green) network integration curve dominated the NetProphet (Fig 
13 
 
2.2, Purple) and PWM binding specificity based (Fig 2.2, Yellow) network curves. We computed 
the area under the precision-recall curve (AUPRC) and found that the AUPRC for the 
NetProphet+PWM curve is 1.8 fold and 1.4 fold greater than the NetProphet and PWM network 
AUPRCs, respectively. Importantly, we have observed similar integrated network improvements 
when using a functional network inferred from a different large-scale gene deletion expression 
dataset (Kemmeren et al. 2014), and when using a physical network constructed from protein-
binding microarray (PBM) obtained PWMs (data not shown), indicating that integrating TF 
DNA binding specificities should generally improve network models.  
2.5.2 Distinguishing good from bad binding specificity models  
Inspired by the observed improvements gained by combining functional and physical 
networks, we decided to integrate the processes of gene regulatory network inference and de 
novo DNA binding motif discovery. Performing de novo DNA binding motif discovery will 
allow us infer novel TF binding specificities and expand integrative network improvements 
beyond the confines of experimentally derived PWMs. Since computational motif discovery has 
high false positive rates, novel methods were required to select only accurate PWM models of 
TF binding specificity. Without the ability to distinguish accurate from inaccurate PWMs, 
integration of DNA binding specificities into an integrative network model would likely decrease 
model quality. 
To identify accurate PWMs for each TF, we compared the target rankings produced by 
the PWM models with the target rankings produced by NetProphet. Similar to a published 
approach which links motifs to TFs (Verfaillie et al. 2014), we hypothesized that target gene 
rankings from an accurate PWM for a TF will agree with the NetProphet target rankings for the 
TF significantly better than target rankings produced by random PWMs. We investigated many 
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potential metrics to measure the relationship between the NetProphet target rankings and PWM 
based target rankings. We computed the similarity between the rankings by correlation (Pearson, 
Spearman, and Kendall), and mutual information. We separated the NetProphet targets into two 
binary sets of bound and unbound targets, and compared the PWM-based ranking of targets to 
these categorical sets using AUPRC and Fisher’s exact test. Also, we fit a linear regression 
model to explain target gene expression form PWM scored binding potential. We used the 
magnitude of the regression coefficient as a final measure of the PWMs accuracy.  
To evaluate these metrics, we used each one to score the relationship between the 
NetProphet target set rankings of each TF and the target rankings produced by scanning the 
ScerTF PWM of each TF. For each PWM, we standardized the PWM’s relationship score 
(converted to Z-scores) with each NetProphet target set. Then, we assessed the degree to which 
higher scores were assigned when the NetProphet and PWM target set rankings were generated 
for the same TF, rather than different TFs. We plotted the mean Z-scores of target set rankings 
generated for the same TF (Fig 2.3). We found that using Pearson correlation, Fisher’s exact test, 
and the magnitude of the regression coefficient explaining gene expression from binding motifs 
were significantly better than other metrics at matching each NetProphet target set with the 
correct PWM. We decided to use the Pearson correlation coefficient for subsequent analysis due 
to its ease of use, and computational speed. 
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Figure 2.3. Investigation of methods to identify good binding specificity models. Barplot showing the ability of 
different metrics to identify the binding specificity model of each TF. The mean of the z-scores assigned to the true 
binding specificity models is plotted for each metric. 
2.5.3 Integration of Network and DNA Binding Specificity Inference  
With metrics capable of selecting accurate PWMs by comparing PWM based ranking of 
target genes to NetProphet ranking of target genes, we refocused on integrating de novo inferred 
PWMs into a network model. We used the NetProphet network as our functional network. We 
used COSMO (Bembom et al. 2007), a MEME-type motif finder, for PWM inference. In total 
we discovered five potentially different PWMs for each TF by inferring a single PWM for each 
of 5 expression pattern based clusters of NetProphet predicted targets. We assigned confidence 
scores to each PWM by utilizing our method to distinguish good from bad binding specificity 
models. Specifically, the confidence score for each PWM was the Z-score of Pearson correlation 
coefficient of the target set rankings produced by the PWM and matching NetProphet target set. 
For each TF we scanned all 5 PWMs over target promoter sequences and combined scores by 
weighted averaging, with each PWM’s confidence score serving as its weight. We then 
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constructed an integrated network by computing the geometric mean of scores in the functional 
and physical networks. To evaluate the integrated network, we plotted precision and recall of the 
NetProphet network (Fig 2.4.A, Purple), inferred PWM based network (Fig 2.4.A, Yellow), and 
the NetProphet + inferred PWM network (Fig 2.4.A Green). 
 
Figure 2.4.A. Precision recall curves showing the recovery of ChIP-supported interactions by the NetProphet 
network (purple), binding potential network constructed from inferred binding models (Yellow), and integrated 
network (green). Random ChIP recovery is shown by the gray dotted line.  
The integrative network had an AUPRC that was 1.3 fold greater than the NetProphet 
alone. Interestingly, this improvement occurs even though the physical network constructed 
using inferred PWMs (AUPRC: 0.1) is much less accurate than the physical network constructed 
using known PWMs (AUPRC: 0.19). 
Next, we evaluated the accuracy of the inferred PWMs. We focused on a set of 187 
inferred PWMs of TFs that have a known PWM (Spivak & Stormo 2012). Our correlative 
method for assigning confidence scores to inferred PWMs classified 38 as strong (Bonferroni 
corrected P-value <= 0.01), 25 as medium (Bonferroni corrected P-value between 0.01 and 0.2), 
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and 124 as weak (Bonferroni corrected P-value > 0.2). We evaluated these confidence 
classifications by comparing the classifications to the accuracy of the inferred PWMs by aligning 
the inferred PWMs with the true PWMs (Fig 2.4.B). We found that inferred PWMs in the strong 
confidence bin aligned better with their matching known PWMs then the PWMs in either the 
medium (Mann-Whitney U test p-value < 0.05) or weak bins (Mann-Whitney U test p-value < 
10
-4
). 
 
Figure 2.4.B. Accuracy of inferred PWMs is predicted by their confidence scores. Barplot showing the mean 
significance of inferred PWMs aligned with their matched known PWM. The inferred PWMs were binned by the 
confidence score of the inferred PWM. Turquoise: High confidence, Red: Medium confidence, Blue, low confidence 
2.5.4 Improving DNA Binding Specificity Inference  
Although we were able to improve the structural accuracy of the inferred network by 
integrating inferred PWMs, we were only able to infer high confidence PWMs for 38 of the 187 
S. cerevisiae TFs. In order to approach the network model improvements demonstrated for 
known PWMs, we must do better. Therefore, we investigated strategies to improve PWM 
inference. 
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Many TFs are enriched to either up-regulate or down-regulate their direct targets, and 
these TFs are classified as activators or repressors respectively (Kemmeren et al. 2014). 
Activator/Repressor classification knowledge can benefit both motif discovery and network 
inference by modifying the confidence in each TF-target interaction based on a comparison of 
the expected and observed effect of the TF on the target. However, these classifications do not 
exist for many less well-studied organisms. Therefore, instead of using the TF classifications 
directly, we used the existence of these TF classifications as motivation for performing DNA 
motif discovery separately on the activated and repressed targets of each TF. As an initial 
validation of this approach, we binned NetProphet predicted targets of the C. neoformans TF 
Usv101 (Fig 2.5.A, Top) by their confidence score and regulatory sign (activated/repressed by 
Usv101), and identified the bins that are enriched with Usv101 motif hits (Fig 2.5.A, Bottom). 
We found that the most confidently repressed targets of Usv101 (top left bins) were also the bins 
most enriched for Usv101 motif occurrences (bottom left bins shaded red). Further, the motif 
recovered from the repressed targets of Usv101 was confirmed by ChIP experiments (Figure 
3.6.D).  
 
Figure 2.5.A. Interaction signs aid in DNA binding motif discovery. Top row: The targets of Usv101, a C. 
neoformans TF, binned by NetProphet confidence and predicted regulatory sign (activation or repression). Bottom 
row: Heatmap of occurrences of the Usv101 DNA binding motif in the promoter region of the binned genes. Red 
shading indicates more occurrences of the motif, blue indicates fewer.  
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We also investigated a second approach to improve binding specificity inference which 
was motivated by the observation that TFs with similar DBDs also tend to have similar PWMs 
(Weirauch et al. 2014; Jolma et al. 2013). To evaluate this observation in S. cerevisiae we 
computed the DBD homology and PWM similarity for all pairs of TFs. DBD homology was 
computed using BLASTP (Altschul et al. 2007) and PWM similarity was computed using 
TOMTOM (Gupta et al. 2007). For each DBD homology significance threshold, from an E-value 
of 1 to an E-value of 10
-30
, we plotted the fraction of DBD homologous TFs that also have 
similar PWMs (Fig 2.5.B). Confirming previous publications (Weirauch et al. 2014; Jolma et al. 
2013), we observed a logistic trend in which more homologous DBDs were more likely to have 
similar PWMs. 
 
Figure 2.5.B. Relationship between DBD homology and PWM similarity for S. cerevisiae TFs. DBDs of all pairs of 
S. cerevisiae TFs were aligned and for each bin of DBD homology, computed as –log10 E-value), the fraction of TF 
pairs with similar PWMs was plotted (PWM alignment E-value < 1). 
We utilized this relationship between DBD homology and PWM similarity to improve 
PWM inference by computing a weighted average of NetProphet target confidence scores for 
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TFs with similar DBDs. By taking the weighted average of NetProphet target confidence scores, 
the top NetProphet targets for a TF will be targets that are shared by multiple TFs with similar 
PWMs, enriching the top targets for genes that have the right binding motif family in their 
promoters. Weights were assigned to each TF’s NetProphet target set fitting a logistic curve to 
the relationship between DBD homology and PWM similarity (Figure 2.5.B). Therefore, to 
generate DBD modified NetProphet target set confidence scores for a TF, the TF’s target set 
confidence scores were given a weight of 1 and combined with other target set confidence scores 
for TFs that have similar DBDs (E-value < 10
-10
), each weighted by their DBD similarity to the 
original TF. 
Next we performed DNA motif discovery using the DBD modified NetProphet target 
confidence scores. The motif finding tool FIRE was used to identify sequence-specific binding 
motifs (Elemento et al. 2007). FIRE identifies a set of 7-mers, that can be converted to a PWM, 
whose presence or absence in a given regulatory region share strong mutual information with 
functional information about the corresponding genes (e.g. gene expression). In this case, the 
functional information used were the DBD modified NetProphet target confidence scores. We 
used FIRE to discover DNA motifs in S. cerevisiae and C. neoformans. For each of these 
organisms we counted the number of motifs FIRE discovers through mutual information with 
original NetProphet confidence scores, signed confidence scores, DBD modified confidence 
scores, and signed DBD modified confidence scores (Fig 2.5.C). We found that FIRE discovered 
an average of 2.7 fold and 1.8 fold more motifs when using the signed NetProphet scores and 
DBD NetProphet scores respectively compared to using the original NetProphet scores. In 
addition, using both sign and DBD homology information together allowed FIRE to recover the 
most motifs, an average of 3.7 fold more motifs than using the original NetProphet scores. 
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Figure 2.5.C. DBD homology and interaction sign aid DNA binding specificity inference. Barplot showing the 
number of DNA binding motifs inferred by FIRE when using each of four different networks. The number of motifs 
is displayed for S. cerevisiae (turquoise) and C. neoformans (red). 
2.5.5 Inference of DNA Binding Specificities in C. neoformans  
Although we confirmed that using regulatory signs and DBD homology allowed us to 
recover more PWMs, the accuracy of the inferred PWMs must still be assessed. We evaluated 
the correctness of each inferred C. neoformans motif using several metrics including FIRE 
reported motif confidence scores, motif occurrence conservation in C. neoformans JEC21, and 
PWM similarity for DBD homologous S. cerevisiae TFs. Using these evaluation metrics, we 
separated inferred motifs into three confidence bins (Fig 2.6). The first bin consisted of the three 
ChIP motifs inferred using BioProspector on the ChIP defined target sets of Gat201, Nrg1, and 
Usv101. The second and third bins consist of high and medium confidence motifs inferred using 
FIRE with the signed DBD modified NetProphet predicted target sets. The high and medium 
confidence motif sets both passed all initial evaluation criteria; however, the high confidence 
22 
 
motif set had better agreement with the NetProphet predicted target scores than the medium 
motif confidence set. In total, the PWMs increased the number of C. neoformans TFs with 
known binding specificities from 2 to 18. In addition, for each TF with a motif, the regulatory 
role of the TF (activator / repressor / both) was assessed by comparing the enrichment of 
activated and repressed targets with likely bound targets. 
 
Figure 2.6. Logos representing the DNA binding specificities of 18 Cryptococcus TFs with supporting evidence. 
The three logos at the top of the left column were inferred from ChIP data using BioProspector and the remaining 15 
were inferred from NetProphet scores using FIRE. Cneo TF: Cryptococcus TF identifiers and inferred function as 
activator, repressor, both, or unknown. Motif: logos. Scores: Our overall confidence in the accuracy of the motif 
followed by the mutual information Z-score from FIRE, the robustness score from FIRE, and whether the motif was 
highly conserved in the promoters of genes in Cryptococcus serotype D strain JEC21 that are orthologs of the targets 
of the indicated KN99 TF. Motif align: List of S. cerevisiae TFs whose motifs in the ScerTF database show the 
strongest resemblance to the inferred motif for the indicated Cryptococcus TF. S. cerevisiae TFs are listed in order 
of similarity, starting with the TF that is most similar and ending with the supporting ortholog chosen on the basis of 
similar DNA binding domain (DBD) and similar sequence specificity. For each S. cerevisiae TF, E-value output by 
TOMTOM for the alignment of its motif to that of the indicated C. neoformans TF is shown. The best possible 
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support for the assignment of a motif to a C. neoformans TF is an S. cerevisiae TF with a highly similar DBD that 
also has highly similar sequence specificity (e.g. Nrg1, Usv101, Swi6, Cir1, Rim101, and Mbs1). DBD Align: S. 
cerevisiae TFs listed in order of the similarity of their DBDs to the DBD of the indicated C. neoformans TF, ending 
with the supporting ortholog chosen on the basis of similar DBD and similar sequence specificity. For each S. 
cerevisiae TF, the percent protein identity of its DBD to that of the C. neoformans DBD is listed. 
2.6 Discussion 
In this chapter we’ve demonstrated that functional network models can be improved by 
integrating physical TF binding data. We then showed that novel PWMs can be inferred de novo 
from NetProphet rankings of targets, and that these novel PWMs can be used to improve the 
network model structure. Finally, we investigated methods to improve de novo inference of DNA 
binding specificities. We showed that NetProphet interaction confidence scores modified by 
adding regulatory signs and utilizing DBD homology can improve the recovery of DNA binding 
motifs. A clear next step for this work is to re-evaluate the structural improvement to the network 
model by integrating inferred physical binding information (Appendix Figure 1). 
In this chapter we only attempted a single round of gene network inference, de novo 
DNA binding specificity inference, and model integration. However, we believe that these 
inference steps could be continuously reapplied until no new PWMs are recovered. More 
sophisticated methods for integrating PWMs into the network model would likely be required to 
benefit from iterating these processes. Specifically, integrative approaches that modify the entire 
network, not just the targets of the TFs with inferred PWMs are required so that the target sets of 
TFs without a PWM are modified. A possible approach, similar to the TILAR method, would use 
binding information to influence the regression based inferred network model through applying 
adaptive weights to the L1 LASSO penalty (Zou 2006). 
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2.7 Methods 
2.7.1 Scanning PWMs and constructing a physical binding network 
Each TF binding based network was constructed by using FIMO (Grant et al. 2011) to 
scan PWMs over the 600 bases upstream of each gene’s transcription start site. Significant PWM 
hits with P-value < 0.005 were used to score binding potential. For each TF, two models of 
regulation were considered, a strong-site model in which target genes are scored based on the 
maximum negative log P-value of significant PWM hits, and a weak-site model in which target 
genes are scored based on the sum of the negative log P-values of significant PWM hits. The 
strong and weak-site models were normalized on a per-TF basis so that the maximum target 
binding score per-TF was 1. The final physical binding network was constructed by computing 
the geometric mean of the strong and weak-site models of binding. 
2.7.2 Combining functional and physical regulatory networks 
To construct causative network models, the underlying functional and physical networks 
were normalized so that the maximum interaction score for each model was 1 and combined by 
computing the geometric mean of their scores.  
2.7.3 Aligning PWMs 
 To assess the accuracy of inferred PWMs, we aligned the inferred PWMs against 
a collection of known S. cerevisiae PWMs (Spivak & Stormo 2012) using TOMTOM (Gupta et 
al. 2007). Inferred PWMs were considered accurate if they aligned well to the known correct 
PWM or to another PWM for a TF with a similar DBD.  
25 
 
2.7.4 Computing DBD homology 
The DBD homology between pairs of TFs was computed by extracting the DBD of each 
TF, then aligning the DBDs. The DBD portion of the protein sequences of every S. cerevisiae 
(Engel, et al., 2014) and C. neoformans (Cryptococcus neoformans var. grubii H99 Sequencing 
Project) TF was identified using the NCBI Conserved Domain Database search tool (Marchler-
Bauer et al. 2013). The DBD sequences of each TF were extracted and aligned to each other 
using BLASTP (Altschul et al. 1997) version 2.2.29. 
2.7.5 Evaluation of C. neoformans inferred PWMs 
Several metrics were used to evaluate the correctness of each inferred motif. First, FIRE 
performs extensive randomization tests to asses the relationship between the motif and functional 
data. A cutoff of 8 was set on the FIRE reported Z-score of the MI value between the motif and 
NetProphet target set, compared with random target sets. A cutoff of 7/10 was set on the FIRE 
robustness score, which measures the robustness of the MI significance by 10 re-calculations of 
MI after randomly removing one-third of the genes. Inferred motifs with scores below these 
cutoffs were rejected. These cutoffs help ensure that inferred motifs were likely true functional 
DNA recognition motifs for a TF in C. neoformans. Although conservation was not used as a 
rejection criterion, the conservation of the motifs was also assessed using FIRE by comparing the 
locations of motif occurrences in the promoters of C. neoformans H99 and C. neoformans 
JEC21. Network-level conservation of each inferred motif was assessed and motifs with 
conservation index >= 0.95 were defined as conserved. This index is the fraction of all possible 
7-mers that are less conserved than the 7-mers permitted by the inferred motif. To also ensure 
that the true functional motif is linked to the appropriate TF, the inferred motif was required to 
align well (TOMTOM reported Q-value <= 0.5) to a known S. cerevisiae motif whose TF was 
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required to share significant DBD homology (BLASTp E-value <= 1e-5) with the C. neoformans 
TF of the aligning motif. 
2.7.6 Inferring regulatory sign of C. neoformans TFs 
To assign a regulatory role for each TF with an inferred PWM, the NetProphet-predicted 
activated and repressed targets of the TF were compared to the targets predicted to be bound by 
the TF (either by ChIP, or high scoring PWM hits). Only interactions in the top 20,000 
NetProphet interactions were considered to identify activated and repressed targets of a TF. The 
significance of binding of activated and repressed targets was computed in two ways. First, for 
TFs with an inferred motif, a two-sample Mann-Whitney U test was used to assess the 
significance of higher binding potential scores of activated (repressed) targets than the null 
background of all other possible targets. Second, for TFs with ChIP evidence, a Hypergeometric 
enrichment test was used to assign a P-value to the overlap between ChIP supported targets and 
activated (repressed) targets. The P-values were adjusted using the Bonferroni correction. If a TF 
had significant (p < 1e-3) enrichment for binding its activated (repressed) targets, then the TF 
was defined as an activator (repressor). If a TF had significant enrichment for binding both its 
activated and repressed targets, then the TF was defined as both an activator and a repressor. Any 
TF without a significant (<1e-3) adjusted p-value was not assigned a regulatory sign. 
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Chapter 3: 
Model-driven mapping of transcriptional 
networks 
3.1 Abstract 
Key steps in understanding a biological process include identifying genes that are 
involved and determining how they are regulated. We developed a novel method for identifying 
transcription factors (TFs) involved in a specific process and used it to map regulation of the key 
virulence factor of a deadly fungus, its capsule. The map, built from expression profiles of 41 TF 
mutants, includes 20 TFs not previously known to regulate virulence attributes. It also reveals a 
hierarchy comprising executive, mid-level, and “foreman” TFs. When grouped by temporal 
expression pattern, these TFs explain much of the transcriptional dynamics of capsule induction. 
Phenotypic analysis of TF deletion mutants revealed complex relationships among virulence 
factors and virulence in mice. These resources and analyses provide the first integrated, systems 
level view of capsule regulation and biosynthesis. Our methods dramatically improve the 
efficiency with which transcriptional networks can be analyzed, making genomic approaches 
accessible to labs focused on specific physiological processes. 
3.2 Background 
In this work we present an efficient means of comprehensively mapping the network of 
transcription factors (TFs) that regulate a particular physiological process. Our approach cycles 
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through deletion of TFs, expression profiling of TF mutants, model construction, and model-
directed selection of TFs for the next round of deletion. This predictive genetics approach 
identifies TFs that affect the process of interest, providing a valuable complement to undirected 
mutagenesis and screening. Simultaneously, it builds a network model that explains how the TFs 
affect the process, yielding novel insights into the biological system under study. 
Mapping the network that regulates a specific process requires knowing which TFs affect 
that process. One way to identify such TFs is to screen comprehensive mutant libraries, but 
generating such libraries is not always feasible. Furthermore, genome-scale screening assays 
must be fast and scalable; such assays may not exist for the process of interest or may be less 
sensitive than other, more laborious assays. An alternative approach is to map the targets of all 
TFs encoded in a genome by using methods such as chromatin- immunoprecipitation (ChIP) or 
large-scale TF deletion and expression analysis. However, undirected, genome-wide approaches 
are costly and inefficient for probing a specific biological process in detail. We report a model-
guided approach that addresses all of these problems by focusing experimental effort on the TFs 
most likely to be involved in the process of interest. Furthermore, our approach generates a 
network that provides mechanistic explanations for the phenotypes of TF deletion mutants. 
Our approach alternates network building by using an algorithm we call NetProphet with 
identifying relevant TFs by using an algorithm we call PhenoProphet. NetProphet is a validated 
method for mapping direct, functional regulation that significantly outperforms other network 
mapping methods (Haynes et al. 2013). It requires only gene expression profiles of strains in 
which TF expression has been perturbed (by gene deletion, mutation, overexpression, or RNAi) 
and wild-type controls, data that can be gathered in a reliable, scalable way by most molecular 
biology labs. It therefore offers significant advantages over alternatives such as ChIP-seq, which 
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requires reoptimization for every TF studied (Landt et al. 2012) and follow-up experiments to 
determine which binding events lead to functional regulation. NetProphet works by combining 
differential expression (DE) analysis with co-expression analysis. In the DE analysis, genes that 
are strongly differentially expressed between a TF-deletion strain and a wild- type (WT) strain 
are considered potential targets of the TF. In the co-expression analysis, genes whose expression 
is strongly correlated with that of a TF (either positively or negatively) across the expression 
profiles are considered potential targets of the TF, enabling NetProphet to identify targets for 
TFs that have not been directly perturbed (see Haynes et al. 2013). PhenoProphet, described here 
for the first time, assigns each TF a score representing its confidence that deletion of that TF will 
yield some phenotypic change of interest. The score of each TF is based on the degree to which 
its NetProphet-predicted targets are enriched for genes associated with the phenotype of interest. 
We demonstrate the power of combining NetProphet and PhenoProphet by mapping the 
network that regulates the major virulence factor of a pathogenic yeast, Cryptococcus 
neoformans. C. neoformans is a basidiomycetous yeast, with a 19 Mb genome encoding ~7000 
genes (Janbon et al. 2014), that diverged from ascomycetes like S. cerevisiae roughly one billion 
years ago (Hedges et al. 2004). It is also an opportunistic pathogen that is responsible for over 
600,000 deaths per year worldwide (Park et al. 2009). Multiple factors influence cryptococcal 
virulence (Srikanta et al. 2014), including the production of protective structures like melanin 
and its major virulence factor, a polysaccharide capsule. Capsule polysaccharides are both 
displayed on the cell surface and shed from the cell. The capsule grows large upon entry into a 
mammalian host, a process that can be recapitulated by a variety of host-like conditions in vitro 
(Zaragoza and Casadevall 2004). 
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3.3 Related Work 
The initial TFs implicated in regulating the virulence factors of C. neoformans are almost 
uniformly major regulators of virulence which are directly downstream of the signaling 
transduction pathways related to virulence factor induction conditions. The work which 
identified these initial TFs relied upon protein conservation, genetic disruption, and microarray 
based screening. For example, the iron responsive TF Cir1, which is required for virulence in a 
mouse, was identified by searching the C. neoformans genome for an ortholog of the S. 
cerevisiae iron regulators (Jung et al. 2006). In addition, Nrg1, a TF required for capsule 
production and cell wall integrity, was identified through microarray analysis of cAMP activated 
genes (Cramer et al. 2006). Although these studies identified many of the major virulence 
regulators, new methods were required to expedite understanding by moving beyond the single 
gene study approach.  
One of the largest studies of this organism was a large-scale genetic screen which 
identified dozens of previously uncharacterized genes that are linked with several assayed 
virulence factors (Liu et al. 2008). For this genetic screen, a total of 1,201 gene knockout 
mutants were generated and each mutant was screened for in vivo proliferation in murine lung 
tissue, in vitro capsule formation, in vitro melanization, and growth at body temperature. Several 
TFs important for regulating cryptococcal virulence factors were identified in this screen 
including GAT201, a key regulator of virulence, which is required for proper induction of large 
capsules and also regulates melanization.  
 Recent work on C. neoformans has started to incorporate Bioinformatics and Systems 
Biology techniques to study the capsule virulence factor. Haynes et al. identified a set of 880 
capsule signature genes whose expression significantly correlated with a capsule size in various 
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conditions (Haynes et al. 2011). One of those genes was Ada2, a regulator of stress response 
required for full induction of capsule. As a beginning step toward identifying the broader 
network controlling capsule regulation, expression profiles of ada2, cir1 and nrg1 were used to 
place Ada2 in a network model of capsule regulation. 
Although several TFs involved in capsule regulation have been identified, however large 
gaps remain in our understanding of capsule regulation (Rodrigues et al. 2011; O'Meara and 
Alspaugh 2012; Kwon-Chung et al. 2014). Most of the downstream capsule biosynthetic 
machinery remains to be discovered and current knowledge of capsule regulation is incomplete 
and fragmented. This offers an ideal opportunity to apply model-guided network mapping. In 
this work, we present the first integrated, systems level view of capsule regulation and 
biosynthesis, which in turn produces unexpected insights into cryptococcal virulence. 
3.4 Approach 
We have developed a novel, predictive approach to identifying TFs related to a 
physiological process of interest and mapping their regulatory targets. This approach consists of 
a cycle (Fig. 3.1) in which TF deletion strains are subjected to phenotyping and expression 
profiling and network models are constructed from the expression profiles by using NetProphet. 
PhenoProphet is then used to predict additional TF genes which, when deleted, will influence the 
process of interest. These genes are then deleted and the phenotypes and expression profiles of 
the resulting mutants are fed back into the cycle. The genome-wide network models resulting 
from this process can be analyzed in multiple ways, including modeling TF binding specificity 
and predicting TF function based on target gene sets. 
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Figure 3.1. NetProphet-PhenoProphet workflow. Yellow, steps involved in network modeling; blue, steps involved 
in network refinement to elucidate a specific process of interest; green, products of genome-wide network analysis. 
3.5 Results 
3.5.1 Expression-based network mapping predicts TFs involved in capsule 
regulation  
We selected deletion strains to make and profile in several stages. First, we deleted genes 
encoding 11 regulators previously reported to participate in capsule synthesis: 8 DNA-binding 
TFs and 3 signaling proteins (Appendix Table 1, ‘Literature’). In the second stage, we deleted 17 
genes encoding putative DNA binding proteins based on the correlation of their expression levels 
with capsule size in various conditions (Haynes et al. 2011; Appendix Table 1, ‘Correlation’). 
We grew these 28 deletion mutants and 3 others (Appendix Table 1, ‘Other’) in capsule-inducing 
conditions and assayed them for capsule size. We developed custom software to facilitate precise 
measurement of capsule thicknesses, enabling statistical analysis of thickness distributions. We 
further subjected all of the mutant strains to expression profiling by RNA-seq in biological 
triplicate after a shift to capsule- inducing conditions. We used the expression profiles of these 
strains and WT controls as input for NetProphet to map the capsule regulation network (Fig. 3.1). 
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To select the final group of genes to delete, we applied PhenoProphet to the NetProphet-
generated network along with 68 genes that have been reported to play a role in capsule 
production (Appendix Table 2.A). These genes encode a variety of enzymes, transporters, 
signaling factors, and proteins of unknown function. When we rank-ordered all TFs by their 
PhenoProphet scores, we found that 14 of the 21 highest-scoring TFs had already been deleted; 
12 of these 14 had altered capsule phenotypes. We deleted an additional 10 top-ranked TFs and 
assayed their gene expression profiles and capsule sizes. Eight of these 10 had altered capsule 
(80%). For comparison, a traditional screen of mutants that included 64 regulator deletions 
identified only 3 required for normal capsule regulation (< 5%) (Liu et al. 2008). 
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Figure 3.2. TF mutants have significant virulence-related phenotypes. For capsule the difference in thickness from 
WT (in pixels) is tabulated and also color coded: green, a decrease of ≥10 pixels compared to wild type; blue, a 
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decrease of 3-9 pixels; and yellow, an increase of ≥3 pixels. * denotes strains with WT mean capsule thickness but 
significantly increased variance. For melanin formation, green indicates colonies that were white (no melanin) to 
beige and blue indicates colonies that were brown but lighter than WT. For capsule shedding, green indicates that 
the 3 hour culture supernatant concentration of GXM was ≥8-fold lower than WT; blue, 2-4-fold lower; yellow, 2-
fold higher. For short-term infectivity, fold-change in colony forming units (CFU) in 1 week was calculated (tested 
only for strains with newly discovered capsule phenotypes). Green, >10 times lower than WT; blue, 2 to 10 times 
lower; and yellow, > 2 times higher. In all columns gray indicates no significant change in phenotype. 
Ten of our deletion strains had increased capsule thickness and 17 had reduced capsule 
thickness (Fig. 3.2). Only 11 of the 27 had been previously reported to influence capsule 
thickness. (The phenotype of cells lacking MBS1, which we studied because of its PhenoProphet 
score, was reported while our analysis was in progress (Song et al. 2012).) Fig. 3.3.A shows the 
altered capsule thicknesses of 17 mutants lacking TF-encoding genes that we selected based only 
on expression data, analyzed by either capsule size correlation or PhenoProphet. Almost half of 
our new mutants were hypercapsular, a phenotype that has been relatively rarely reported 
(D'Souza et al. 2001; Bahn et al. 2005; Lee et al. 2009). Many of the mutants with altered 
capsule size also showed significantly increased capsule size variability. Interestingly, two 
mutants, ssn801 and clr2, showed a substantial increase in capsule size variability (2.9-fold, 
p<10
-78 and 1.6-fold, p<10
-18
, respectively) with no change in mean capsule size. 
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Figure 3.3.A. Capsule thicknesses of 17 novel altered capsule mutants. Representative cells of our new mutant 
strains, selected so all have similar cell wall diameter and each has capsule thickness very close to the average 
determined for that mutant. Images are all to the same scale (bar = 5 microns) and ordered by capsule size. Colors 
indicate capsule size groups as in Fig. 3.2. 
We also assessed other virulence-related phenotypes in our uniform collection of 41 
mutants. In addition to displaying capsule polysaccharide on its surface, C. neoformans sheds 
this material into the environment, with adverse effects on the host immune response (Coelho et 
al. 2014). We used a cryptococcal antigen latex agglutination test to assess capsule shedding in 
our strain set. Interestingly, both hyper- and hypocapsular strains showed alterations in capsule 
shedding (Fig. 3.2). Many of our new mutants also had defects in melanin production, a 
virulence factor (Eisenman and Casadevall 2012) (Fig. 3.2). Finally, we tested our new mutants 
for their ability to grow in the mouse lung; 11 showed a significant change in this characteristic 
(Fig. 3.3.B). 
 
Figure 3.3.B. Mouse lung growth of 17 novel altered capsule mutants. Mean ± SEM of infectivity results; the 
horizontal gray bar denotes fold-increase values from 0.5 to 2-fold that of WT. All strains grew like WT on rich 
medium except for fhl1, which had a 2.5-fold higher doubling time. 
About 2/3 of the new mutants with abnormal capsules also showed defects in at least one 
other virulence-related trait (Fig. 3.3.C, left). Several showed defects in all traits measured, 
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including usv101, a novel virulence regulator (Fig. 3.2). We also identified three novel factors, 
Hap2, Bik1, and Mlr1, that are not involved in regulating capsule, but do yield isolated melanin 
defects (Fig. 3.3.C, right); Mlr1 further has no S. cerevisiae ortholog. Notably, all four TF 
mutants with reduced capsule shedding that we tested in mice had an infectivity defect. This 
suggests that capsule shedding is critical for infectivity, regardless of whether surface capsule is 
reduced or enlarged. 
 
Figure 3.3.C. Aberrant phenotypes of new mutants (left) and of all the mutants in Fig. 2 (right). Melanin was scored 
for 37 °C phenotype. 
3.5.2 PhenoProphet accurately predicts which TFs will have altered capsule 
thickness  
A remarkably large fraction of the TFs identified by PhenoProphet were involved in 
capsule regulation (Appendix Table 1). We compared this result to our previous strategy of using 
the correlation of gene expression with capsule thicknesses to predict TF capsule involvement, 
using our previously published correlation scores (Haynes et al. 2011). Of the 17 TFs we 
selected for deletion by the correlation method, 8 had altered capsule thickness (47%); of the 10 
we selected by PhenoProphet, 8 had aberrant or hypervariable capsule thickness (80%). To 
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further compare capsule-size correlation and PhenoProphet to each other and to other methods of 
phenotype prediction, we applied each method to a set of TFs for which the capsule phenotype of 
the corresponding deletion was known. These genes had primarily been deleted because they 
were suspected to have a role in capsule regulation (Appendix Table 2.B). To simulate 
prospective phenotype prediction, we used leave-one-out cross validation, in which each mutant 
phenotype is predicted without using any data derived from that mutant. As a simple, baseline 
prediction method, we considered the hypothesis that TF genes that display significant 
expression changes upon capsule induction are more likely to be required for normal capsule 
induction than those that do not. The data did not support this hypothesis (Fig. 3.4.A, green). 
Next, we considered the possibility that genes whose expression is significantly correlated with 
capsule thickness would be more likely to encode TFs regulating capsule than genes whose 
expression is not correlated with capsule thickness. The data did not support this hypothesis, 
either (Fig. 3.4.A, red). 
 
Figure 3.4.A. Comparison of methods for predicting capsule involved regulators. Four expression-based methods (x-
axis) were used to predict whether cryptococcal regulators are involved with capsule formation (mutants show 
abnormal capsule; dark bars) or not (light bars). The set of genes in each category was then assessed for the fraction 
that actually does influence capsule (y-axis). 
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We next tried a phenotype prediction method called Phenologs, which is based on the 
observation that genes sharing a phenotype in one organism often share phenotypes in another 
organism, even when the phenotypes themselves appear to be unrelated (McGary et al. 2010). 
However, TFs with positive Phenolog scores were not significantly enriched for those that affect 
capsule thickness (Fig. 3.4.A, blue; Fisher’s exact p=0.43), nor were the Phenolog scores of TFs 
that do affect capsule thickness greater, on average, than those of TFs that do not (Fig. 3.4.B, 
blue; Mann-Whitney U test p=0.33). Thus, Phenolog scores do not have discriminative value in 
this application. In contrast to all of these methods, TFs with positive PhenoProphet scores were 
significantly enriched for those that affect capsule thickness (Fig. 3.4.A, orange; Fisher’s exact p 
< 0.03). Furthermore, the mean of PhenoProphet scores for TFs that affect capsule thickness was 
significantly greater than the mean score for TFs that do not affect capsule thickness (Fig. 3.4.B, 
orange; Mann-Whitney U test p < 0.02).  
 
Figure 3.4.B. Comparison of scores assigned by methods for predicting capsule involved regulators. Mean and SEM 
of Phenolog and PhenoProphet scores for genes which are capsule involved (dark bars) or not (light bars). 
The predictive power of PhenoProphet relative to the other methods is confirmed by 
receiver operating characteristic analyses (Fig. 3.4.C). 
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Figure 3.4.C. Receiver operating characteristic analysis comparing the indicated methods for phenotype prediction 
to random expectation (dotted line). 
Next, we investigated the effect of the number of expression-profiled TF deletion strains 
on the accuracy of PhenoProphet. The results showed that the predictive accuracy of 
PhenoProphet exceeded chance (and the accuracy of Phenologs) even when the number of 
profiled TF-deletion strains given to NetProphet was reduced to 25% of the total (11 TFs 
deleted; Fig. 3.5.A). Providing profiles of more TF-deletion strains increased accuracy, 
confirming that PhenoProphet depends on the NetProphet network for its accuracy. In 
applications where no TF network is available and the number of TF-deletion strains that can be 
profiled is less than 10 another method (such as Phenolog analysis) may be most useful. We also 
investigated the effect of the number of known capsule-involved genes, with results similar to 
those described above for deletion-strain profiles (Fig. 3.5.B.) 
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Figure 3.5.A-B. Examination of PhenoProphet accuracy in varying conditions. Panel A, effect of number of 
regulator-deletion expression profiles given to NetProphet on the accuracy of PhenoProphet. Panel B, effect of the 
number of known phenotype-linked genes on PhenoProphet accuracy. 
3.5.3 NetProphet predicts functional, direct binding of TFs to their targets 
We previously validated NetProphet in S. cerevisiae using data from ChIP-chip and 
protein-binding microarrays (Haynes et al. 2013). To validate NetProphet in C. neoformans, we 
focused on Gat201, the only cryptococcal TF for which ChIP data was available (Chun et al. 
2011); Nrg1, a well studied capsule regulator (Cramer et al. 2006); and Usv101, a capsule 
regulator described here for the first time. We epitope-tagged the last two and carried out ChIP-
seq. We then tested the NetProphet-predicted targets of Usv101, Gat201, and Nrg1 for 
significant overlap with their ChIP-positive targets. NetProphet assigns a confidence score to 
each potential target of a TF, so we tested top-scoring target groups of various sizes, from 40 to 
200. For all three TFs, the 40 most confident NetProphet predictions were highly enriched for 
ChIP-positive targets, as compared to the number that would be expected if 40 genes were 
chosen at random (Fig. 3.6.A-C). 
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Figure 3.6.A-C. ChIP enrichment of NetProphet predicted targets. Colored bars, cumulative fold-enrichment of the 
top NetProphet-predicted targets of each TF for ChIP-positive targets, relative to the fraction of ChIP-positive 
targets among all genes; square symbols, significance of the enrichment (pval). The horizontal axis indicates the 
number of top-ranked NetProphet-predicted targets considered. 
To further test our predictions, we compared models of TF binding specificity inferred 
from the NetProphet-predicted targets to specificity models derived from ChIP (Fig. 3.6.D-F, top 
two logos). For both Usv101 and Gat201, the Cryptococcus motifs derived from NetProphet 
predictions and from ChIP data were highly similar, whereas for Nrg1 there were significant 
differences between the two. For comparison, we extracted a motif for the closest homolog of 
each TF in S. cerevisiae from the ScerTF database (Spivak and Stormo 2012) (Fig. 3.6.D-F, 
bottom logo). The motif of C. neoformans Usv101 (confirmed independently by NetProphet and 
ChIP) has diverged substantially from the motif of S. cerevisiae Usv1 on one side. No motif is 
available for Gat2, the ortholog of Gat201, but the motif of Ecm23, the next best homolog, 
shows the expected GATA family resemblance. The motif for S. cerevisiae Nrg1 supports the 
ChIP-derived Cryptococcus motif over the NetProphet-derived motif; this is likely because the 
NetProphet-predicted Nrg1 targets include some indirect targets regulated by TFs downstream of 
Nrg1. 
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Figure 3.6.D-F. Comparison of derived binding motifs. For the indicated TFs, C. neoformans binding motifs derived 
from the promoters of NetProphet-predicted targets (top) or from the regions around ChIP-seq peaks (middle) are 
compared to S. cerevisiae binding motifs (bottom). 
We then attempted to infer binding specificity models (PWMs) for all other Cryptococcus 
TFs from their NetProphet-predicted target sets (Elemento and Tavazoie 2005). We tested these 
PWMs for significant conservation in the genome of a related species (JEC21, serotype D). We 
also tested each TF to determine whether there was a highly homologous TF in S. cerevisiae with 
highly similar binding specificity, as in Figure 3.6.D, E. In total, 18 PWMs showed both types of 
conservation and were therefore deemed reliable models (Fig. 2.6). Previously, binding 
specificity was known for only 2 TFs in Cryptococcus (Chun et al. 2011; O'Meara et al. 2014), 
both of which strongly support our independently derived PWMs. 
3.5.4 ChIP-experiments validate NetProphet predictions 
We combined NetProphet and ChIP results from Usv101, Gat201, and Nrg1 to produce a 
high-confidence core for our model of the network regulating virulence in C. neoformans (Fig. 
3.6.G). This reveals a highly interconnected subnetwork in which Usv101 represses GAT201, 
consistent with their opposite capsule phenotypes (large vs. small). Usv101 also represses several 
sugar transporters while activating HXT1, a hexose transporter that has a hypercapsular 
phenotype (Chikamori and Fukushima 2005). Usv101 represses, and Gat201 activates, BLP1, 
which is involved in a capsule-independent anti-phagocytic mechanism (Chun et al. 2011). The 
opposing effects of Usv101 and Gat201 on BLP1, which promotes fungal survival during 
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infection, are consistent with their generally opposing roles in regulating virulence and their 
opposite capsule phenotypes. Usv101 represses BLP1 both directly and via its repression of 
GAT201, forming a coherent feed-forward loop. 
 
Figure 3.6.G. Network diagram showing the three validated TFs with targets supported by both NetProphet and 
ChIP analysis that are relevant to cryptococcal virulence. Round nodes, TFs; square nodes, target genes or gene 
ontology biological process terms for which the targets of the indicated TF are enriched. Blue nodes, mutants are 
hypocapsular; yellow nodes, mutants are hypercapsular; gray nodes, mutants are defective in capsule-independent 
phagocytosis. Edges with arrowheads indicate activation while those with T-heads indicate repression. ChIP 
evidence suggests that Usv101 binds to its own promoter but expression evidence cannot determine whether this 
binding results in activation, repression, or no effect. 
Our data support a previous report (Chun et al. 2011) that Gat201 activates ECM2201, 
encoding a TF, and we report for the first time that the ecm2201 mutant is hypocapsular (Fig. 
3.2). Gat201 has the same effect on capsule size as Nrg1 and works with Nrg1 to stimulate 
expression of GAT204, which encodes a second TF involved in the capsule-independent anti-
phagocytic mechanism (Chun et al. 2011). Both Gat201 and Nrg1 repress some genes involved 
in cell wall synthesis but Nrg1 also activates other genes involved in cell wall synthesis, 
suggesting that cell wall may be reconfigured during capsule induction. Nrg1, which is activated 
by cAMP signaling in Cryptococcus (Cramer et al. 2006), also activates PDE2, encoding a 
phosphodiesterase that reduces cAMP levels (Zaman et al. 2008), thus adding a slow, 
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transcriptionally-mediated negative feedback loop in cAMP signaling to the fast, post-
translational negative feedback loops that have been reported (Hicks et al. 2005; Kronstad et al. 
2011). 
Nrg1 further activates UGD1, MAN1, and UXS1, which encode glycoactive proteins (Fig. 
3.6.G), as well as CLC-A and CPL1, which encode proteins involved in maintaining ion balance 
(Zhu and Williamson 2003 and our unpublished data). Deletion of any of these five genes results 
in a hypocapsular phenotype. Thus the hypocapsular phenotype of the nrg1 mutant may be 
caused by its failure to activate expression of these five genes. Broadly speaking, the TFs in Fig. 
3.6.G have the same phenotypes as the targets they activate. Furthermore, TFs whose absence 
affects capsule thickness in opposite directions (Usv101 vs. Gat201 and Nrg1) regulate their 
common targets in opposite directions, whereas TFs whose absence affects capsule in the same 
direction (Gat201 and Nrg1) also regulate their common targets in the same direction. 
3.5.5 NetProphet illuminates transcriptional dynamics 
To gain insight into the transcriptional dynamics of cryptococcal capsule induction, we 
performed RNA-seq on WT cells immediately before transfer from rich media into capsule-
inducing conditions and at 1.5, 3, 8, and 24 h after transfer. Considering all genes across the time 
course (Fig. 3.7.A), one pattern that emerged was repression of genes involved in ribosome 
biogenesis, tRNA synthesis and processing, amino acid biosynthesis, and protein transport, along 
with induction of genes involved in specific amino acid degradation and protein degradation; this 
is consistent with the cells accommodating to scarcer nutrients and slower growth. Expression of 
some nuclear genes encoding cytochrome-C oxidase (COX) components declined while 
expression of mitochondrial genes encoding COX components increased. Expression of all 13 
mitochondrial genes increased significantly (mean fold-change 57, median 20). 
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Figure 3.7.A. heat map of genome-wide expression profiling; blue, low expression; yellow, high expression. 
Examples of functional annotations of genes in each cluster are indicated. 
To map the transcriptional dynamics onto our network, we divided TFs whose deletions 
alter capsule thickness into four groups based on their temporal expression patterns (Fig. 3.7.B, 
circles). The most “upstream” acting TFs in the network form a group with slightly increased 
expression at 90 minutes followed by sharply decreased expression over the next 24 hours (Fig. 
3.7.B, Regulator Group 1). This group includes activators of ribosome biogenesis genes and 
repressors of mitochondrially-encoded respiration genes. It also contains repressors of a cluster 
of capsule-involved genes whose expression increases steadily through capsule induction (Fig. 
3.7.B, Box A). This target group includes genes encoding proteins involved in nucleotide sugar 
synthesis and transport, polysaccharide synthesis, and maintenance of inorganic ion and osmotic 
balances. Group 1 includes activators of a set of capsule-involved genes that decreases steadily 
after the first few hours of capsule induction (Fig. 3.7.B, Box B). These declining genes include 
four that encode proteins that promote cAMP/PKA signaling, reinforcing the transcriptionally 
mediated negative feedback on cAMP/PKA signaling noted above. 
47 
 
 
Figure 3.7.B. Regulatory relations among groups of capsule-involved genes clustered by temporal expression 
pattern. Circles, groups of regulators clustered by their temporal expression patterns (insets); text denotes 
representative functions of their activated (green) or repressed (red) targets. Boxes, capsule-involved target genes 
clustered by their temporal expression patterns (insets); text provides examples of target gene functions. Green 
arrows, activation of designated targets; red T-heads, repression of designated targets. Regulator Group 1 is Clr1, 
Hap5, Nrg1, Pkr1, and Ssn801; Regulator Group 2 is Cac1, Cep3, Cir1, Clr2, Fap1, Fhl1, Fkh2, Gat1, Mcm1, 
Pdr802, Sp1, Swi6, and Usv101; Regulator Group 3 is Clr6, Hog1, Mbs1, Ste12alpha, and Tup1; Regulator Group 4 
is Ada2, Clr3, Clr4, Clr5, Ecm2201, Fkh101, Gat201, Hap3, and Rim101. NSS, nucleotide sugar synthesis; NST, 
nucleotide sugar transport; ROS, reactive oxygen species. 
Group 2 is the opposite sign partner of Group 1 and cooperates with it in nearly every 
way: Its expression pattern is opposite that of Group 1 and it regulates mitochondrially-encoded 
respiration genes as well as each cluster of capsule-involved non-TFs in the opposite way from 
Group 1. Since Group 2 is repressed by Group 1 the indirect effects of Group 1 via Group 2 are 
consistent with the direct effects of Group 1. 
As with Group 2, the expression of regulators in Group 3 decreases from time 0 to 90 
min, then reverses course and increases from 90 min to 24 hr. The difference is that Group 2 
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regulators rapidly recover to well beyond their initial levels, whereas Group 3 regulators never 
recover their initial levels. This difference may result from the tendency of Group 2 regulators to 
activate each other, forming positive feedback loops. Group 3 regulators activate genes involved 
in the response to reactive oxygen species (ROS) while repressing certain carbohydrate and 
amino acid transporters. Group 3 regulates a set of capsule-involved genes that has an “L” 
shaped expression pattern (Fig. 3.7.B, Box C) and includes genes involved in amino acid 
biosynthesis and other growth- related processes. 
Group 4 regulators are regulated by all of the other groups but they do not regulate other 
groups, putting them at the bottom of the hierarchy. Their expression increases steadily through 
induction and they include activators of genes involved in metal ion transport and synthesis of 
chitin, a component of cell wall. 
Taken together, these analyses show a hierarchy of TFs (circles), with those expressed in 
an “inverted check-mark” (Group 1) at the top, those that first decrease and then increase in the 
middle, and those that increase steadily at the bottom. Capsule-involved, non-TF genes (boxes) 
are expressed in temporal patterns that are generally consistent with those of their regulators – 
the same pattern for activators and the opposite for repressors. These observations suggest that 
the temporal patterns of downstream genes can in many cases be explained by the patterns of 
their regulators shown in Figure 3.7.B. For example, Group 1 and Group 2 regulators that are 
connected by an edge in the underlying network show an average temporal correlation of -0.84. 
For Group 1 and Group 3, the average correlation is -0.16 and for Group 2 and Group 4 it is 
+0.60. 
The fact that we do not see any delay between the changes in upstream regulators and 
those in downstream targets is consistent with the expectation that the translation of TF-encoding 
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mRNAs and the initial response by target genes should occur on a faster time scale (< 0.5 hr) 
than the interval between samples in our time course (1.5-16.0 hr). 
The hierarchical relationships among these four regulator groups were confirmed by 
comparing the number of factors regulating each regulator to the number of its targets (Fig. 
3.7.C). This analysis shows that the regulators in Group 1 have more targets than regulators, 
those in Groups 2 and 3 have about the same number of targets and regulators, and those in 
Group 4 have more targets than regulators. 
 
Figure 3.7.C. Normalized hierarchy heights (NHH) of regulators in Groups 1-4 of Fig. 3.7.B. NHH is the number of 
outgoing edges minus the number of incoming edges divided by outgoing plus incoming.  
3.5.6 Network analysis reveals mechanisms of capsule biosynthesis regulation 
While little is known about the glycosyltransferase reactions that generate capsule 
polysaccharides, the upstream pathways that form precursors for this process are well defined. 
Nucleotide sugar donors of mannose, galactose, glucuronic acid, and xylose are synthesized in 
the cytosol and transported into the Golgi for use in capsule synthesis (Fig. 3.8.A). We analyzed 
our network to gain insight into the regulation of these key metabolic processes. PSA101 is the 
most heavily regulated of the genes we analyzed, suggesting that it is a key point at which 
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transcriptional regulation affects biosynthesis. Of the two genes encoding GDP-mannose 
transporters, GMT1, which has a much greater effect on capsule size (Wang et al. 2014), is 
regulated by the major capsule regulators Cir1 (Jung et al. 2006), Rim101 (O'Meara et al. 2014), 
and Ada2 (Haynes et al. 2011). GMT2, whose deletion shows a phenotype only when GMT1 is 
also inactivated (Wang et al. 2014), is repressed by Usv101 and activated by Rds2, a TF without 
a significant capsule thickness phenotype. The degree of regulation by capsule- involved TFs 
thus highlights the transporter that is more heavily involved in capsule synthesis. 
 
Figure 3.8.A. Regulation of upstream capsule biosynthetic pathways. Network-derived regulatory relationships 
between TFs and the pathways that make and localize sugar donors for capsule synthesis, considering the top 10,000 
NetProphet edges. Large labeled arrows, synthetic steps; ovals, TFs; cylinders, nucleotide sugar transporters in the 
Golgi membrane. Shapes are labeled with the corresponding gene name and filled blue if the mutants are 
hypocapsular, yellow if the mutants are hypercapsular, and white if the gene has not been deleted (PMM1) or the 
mutants have normal capsule thickness (all others). Arrowheads indicate activation and T-heads repression; edge 
colors reflect the phenotype of the regulator. ASG1+2 represents 3 genes which are normocapsular when deleted: 
ASG1, CCD6, and MAL13; HAP3,5 represents HAP3 and HAP5, both hypocapsular when deleted. Man, mannose; 
Xyl, xylose; GlcA, glucuronic acid; Glc, glucose; Man1, phosphomannose isomerase; Pmm1, 
phosphomannomutase; Psa1, GDP-mannose pyrophosphorylase; Uxs1, UDP- Xyl synthase (Bar-Peled et al. 2001); 
Ugd1, UDP-Glc dehydrogenase (Bar-Peled et al. 2004; Moyrand and Janbon 2004); and Uge1, UDP-Glc epimerase. 
Gmt1 and Gmt2 are GDP-Man transporters (Cottrell et al. 2007; Wang et al. 2014) and Ugt1 is a UDP-Gal 
transporter (Moyrand et al. 2007); transporters for the other precursors have not been identified. 
The TFs that regulate the largest number of genes involved in upstream capsule 
biosynthetic processes are Nrg1, whose mutant is severely hypocapsular, closely followed by 
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Usv101, whose hypercapsular deletion phenotype is reported here for the first time, Cir1, 
Rim101 and Ada2. Regulation of capsule biosynthetic enzymes and transporters is sufficient to 
explain the phenotypes of mutants lacking Cir1, Nrg1, Usv1, and Ada2: Usv101 (hypercapsular) 
primarily represses these pathways while the others (hypocapsular) primarily activate them. The 
hypocapsular phenotype of rim101 is less well explained, as Rim101 appears to repress UXS1 
and GMT1 while activating PMM1 and PSA1. Likewise, the phenotypes of mbs1 and fkh2 are not 
explained by the relationships we have identified, suggesting that some of their other targets may 
have as-yet-unknown roles in capsule synthesis. 
The TFs that regulate the metabolic pathways shown in Fig. 3.8.A also regulate one 
another in what is largely a feed-forward hierarchy (Fig. 3.8.B). Cir1, Nrg1, and Usv101 sit at 
the top of the hierarchy, each regulating multiple other TFs. The other regulator at the top of the 
pathway is Ccd3, which interestingly does not have a capsule size phenotype despite activating 
four TFs with hypocapsular phenotypes. Clr2, Mbs1, Fkh2, Hap5, and Bik1 form an intermediate 
layer, and Hap3, Rds2, Rim101, and Ada2 appear at the bottom of the cascade because they 
regulate enzymes and transporters directly but do not regulate other TFs in this context. Of the 7 
TFs that regulate only one or two biosynthetic genes in Fig. 3.8.A and do not regulate other TFs 
in Fig. 3.8.B, only 1 is required for normal capsule thickness. In contrast, all 5 of the TFs that 
regulate 3 or more genes in Fig. 3.8.A are required. 
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Figure 3.8.B. Network-derived regulatory relationships between the TFs shown in Figure 3.8.A, using the same 
colors and symbols except that TFs are circles. For clarity, only the top 10,000 NetProphet edges were used. 
3.6 Discussion 
NetProphet and PhenoProphet enable individual labs lacking the resources of a genome 
center to systematically and efficiently study the transcriptional regulation of a specific 
physiological process. Currently, the TFs that regulate a process of interest are typically 
discovered by large-scale mutant screens and TF-target relations are mapped in big-science 
projects that do not focus on TFs with specific biological functions (Harbison et al. 2004; Hu et 
al. 2007; Kemmeren et al. 2014). Our approach brings TF discovery and mapping together 
through focused, iterative network construction and analysis. We demonstrated this approach by 
mapping the network that regulates the major virulence factor of Cryptococcus neoformans, a 
deadly human pathogen. Key to the success of this effort was PhenoProphet’s accuracy in 
identifying TFs that are required for normal capsule growth. This enrichment for TFs involved in 
capsule regulation enabled us to perform quantitative capsule-size assays that are more sensitive, 
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but also more labor-intensive, than those used in traditional screens. Our approach enables TF 
networks to be mapped using only gene perturbation and expression profiling, both of which are 
straightforward in most experimental systems. Indeed, the number of TF-perturbation expression 
profiles for mammalian systems is growing rapidly, facilitating the application of our approach 
to mammals. No single approach has perfect sensitivity and specificity, so large-scale mutant 
screens and ChIP-seq remain important complementary methods. Nonetheless, we have filled a 
significant methodological gap between single-gene approaches and undirected genomic 
approaches. 
Using the NetProphet-PhenoProphet approach, we produced a comprehensive map of the 
TF network that regulates cryptococcal capsule size, increased the number of TFs known to 
regulate capsule from 11 to 27, and increased the number of C. neoformans TFs with known 
sequence specificity from 2 to 18. In the course of this work, we generated a rich resource for 
systems biology of fungal virulence. We increased the number of publically available RNA-seq 
profiles from C. neoformans TF-deletion studies 20-fold, more than doubled the total number of 
Cryptococcus expression profiles (including microarrays), presented the first time course of 
expression during capsule induction, and generated virulence-related phenotypes for 41 regulator 
deletion mutants under identical conditions, including all known TF mutants that affect capsule 
size. Taken together, our data sets form the most comprehensive resource for regulatory systems 
biology available for any fungal pathogen. We expect that this data set, like large-scale data sets 
for S. cerevisiae (Harbison et al. 2004; Hu et al. 2007), will catalyze the development of 
powerful new network analysis and phenotype prediction algorithms. 
Our kinetic evaluation of gene expression during capsule induction allowed us to cluster 
major regulators based on their temporal expression patterns. We found that the TFs comprising 
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Group 1 decrease in expression during capsule induction, releasing repression of Group 2 TFs, 
which correspondingly increase in expression. Groups 1 and 2 have strikingly similar net effects 
through opposite expression patterns and opposite effects on target expression, forming coherent 
feed forward loops. Our dynamic analysis also revealed how regulators interact to influence 
general cellular processes as well as capsule synthetic pathways. For example, the Group 1 and 2 
regulators cooperate to induce mitochondrially-encoded respiration genes, resulting in massive 
upregulation of these genes (mean, 57 fold; median, 20 fold). This is interesting because host 
conditions are hypoxic (Erecinska and Silver 2001) and the virulence of Cryptococcus gattii, 
which can cause fatal infections in immunocompetent individuals, is closely associated with 
upregulation of mitochondrial gene expression (Ma et al. 2009). We also integrated our broad 
analysis of transcriptional dynamics with our focused analysis of nucleotide sugar regulation. 
Both analyses highlight hierarchies of transcription factors that are largely consistent with one 
another. They agree that Nrg1 is at the top, regulating many capsule-involved TFs but not itself 
transcriptionally regulated. They further agree that Hap3, Rim101, and Ada2 are at the bottom, 
regulated by many TFs and regulating relatively few, and that Usv101, Mbs1, and Fkh2 play 
both roles, integrating signals from master regulators and distributing them to lower level 
regulators. 
Much of the downstream machinery required for capsule polysaccharide synthesis has 
not yet been identified. We expect that the NetProphet network, in addition to efficiently 
identifying novel capsule regulators, will address this gap. For example, we noticed that 
CNAG_03320 (the more diverged of two cryptococcal homologs of the S. cerevisiae GDP-
mannose pyrophosphorylase Psa1) was regulated by large numbers of capsule-involved TFs, 
suggesting that it might have a role in synthesizing capsule precursors. When we tested this idea 
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by deleting the gene, now named PSA101, the mutants were indeed severely hypocapsular. 
Another way in which the network can highlight relevant biosynthetic machinery is illustrated by 
Ecm2201, a TF that is required for normal capsule growth but does not regulate any other genes 
known to be required for normal capsule. We anticipate that the targets of Ecm2201 and other 
TFs with unexplained phenotypes include missing elements of capsule biosynthetic pathways. 
Filling in these gaps in knowledge about synthesis of a major virulence factor that has no parallel 
in human cells may help identify targets for future antifungal therapy. 
In addition to capsule size, we assayed our matched set of mutants for other virulence-
related phenotypes, including capsule shedding, melanization, and infectivity in a short-term 
mouse model. This revealed some surprising relationships among phenotypes. Many of our novel 
TF mutants that affected capsule thickness also affected infectivity, with both hypercapsular and 
hypocapsular mutants showing reduced infectivity. Hypercapsular mutants were particularly 
impaired in this regard. This is consistent with a recent report that virulence in C. neoformans is 
positively correlated with rate of uptake by macrophages, which is negatively correlated with 
capsule size (Sabiiti et al. 2014). Reduced capsule shedding was a strong and significant 
predictor of reduced infectivity (p. < 0.03). Thickness and shedding were not clearly related, 
suggesting that these processes are independently regulated and that enlarged capsules might 
result from increased production in some cases and reduced shedding in others. We also 
observed that deletion of TFs frequently increases capsule size variability, showing that 
variability is controlled by TFs, probably through negative feedback loops. 
In this work, we report a significant advance in the efficiency with which TFs that 
regulate a specific biological process can be identified and their regulatory networks mapped. 
We further used that technical advance to gain major insights into fungal virulence regulation. In 
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the process we produced a valuable resource for regulatory systems biology of fungal pathogens, 
comprising high quality gene expression and phenotype data produced by a single laboratory 
using a consistent strain background. We expect that our methodological advances will have a 
broad impact in systems biology and that our discoveries and data resources will transform our 
understanding of fungal virulence. 
3.7 Methods 
3.7.1 Materials, strains, and cell growth 
Cell culture media (i.e. Dulbecco’s Modified Eagle’s Medium, D6429), chemicals (i.e. L-
DOPA for melanization, D9628), and PCR primers were from Sigma- Aldrich, PCR purification 
(28106) and gel extraction (28706) kits from Qiagen, and reagents used for RNA-seq, such as the 
SuperScript III Kit (18080) and the mRNA Catcher Plus Kit (K1570), from Life Technologies. 
Strains were made in C. neoformans KN99α (Nielsen et al. 2005) with standard growth at 30 °C 
in yeast peptone dextrose (YPD) medium. For capsule induction, an overnight culture in YPD 
was washed, resuspended in DMEM, and grown at 37°C in 5% CO2. 
3.7.2 Gene manipulation and naming 
A split-marker strategy (Fu et al. 2006) was used to replace specific genomic targets with 
drug resistance cassettes as in (Haynes et al. 2011) and to incorporate HA tags; New gene names 
were CLR, capsule-linked regulator; MLR, melanin- linked regulator; and CCD, capsule-
correlated DNA-binding protein. 
3.7.3 Phenotyping 
Growth in vitro was assessed by cell counts, melanization by colony color on L- DOPA 
agar, and shed capsule polysaccharide by the Cryptococcal Antigen Latex Agglutination System 
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(CALAS®, Meridian Bioscience, Cincinnati, Ohio). To assess capsule thickness, duplicate 
cultures of cells grown for 24 h in inducing conditions were washed and mixed 3:1 (v/v) with 
India ink for imaging. The cell wall and capsule edge of each cell were manually annotated (≥10 
images per culture) using custom software, and the capsule thickness (outer capsule edge 
diameter minus cell wall diameter) of mutants relative to WT cells grown in parallel was 
calculated. Only significant differences (p<10
-7
) of more than 2.5 pixels were reported as altered 
capsule thickness. 
3.7.4 RNA Isolation, RNA-seq, and ChIP-seq 
RNA was isolated by standard methods from ≥3 biological replicates for each strain 
grown for 90 min in capsule-inducing conditions. Libraries for RNA-seq were prepared as in 
(Haynes et al. 2011), barcoded, and pooled in equimolar ratios for multiplex sequencing. ChIP 
studies were performed as in (Haynes et al. 2011), using WT and HA-tagged strains and 
comparing samples subjected to immunoprecipitation (IP) to input material and mock 
precipitated samples.  
3.7.5 Animal Studies 
All animal studies were reviewed and approved by the Animal Studies Committee of 
Washington University School of Medicine and conducted according to NIH guidelines. Groups 
of six 6 week-old female C57Bl/6 mice were inoculated intranasally with 1.25 × 10
4 
cryptococci, 
and lung CFU were determined at 2 h and 7 d post-infection. 
3.7.6 Comparison of phenotype prediction methods 
The accuracy of each method was assessed by comparing its predictions to the 
phenotypes of 50 single-regulator deletion strains that have been analyzed for capsule thickness 
either by us or in published works (Appendix Table 2.B). Most of these genes were deleted 
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because they were thought likely to have capsule phenotypes – they are not a random sample of 
all cryptococcal TFs and 32 of them had altered capsule thickness. Differential expression was 
assessed using standard methods. Capsule size correlation was assessed as in (Haynes et al. 
2011). Phenologs were assessed as in (McGary et al. 2010). The PhenoProphet score of a TF for 
capsule thickness is –log p-value from the hypergeometric test for enrichment of its NetProphet-
predicted targets for genes that are known to have capsule thickness phenotypes. Specifically, the 
PhenoProphet score is the maximum –log p-value over all networks consisting of the top n 
NetProphet predictions, with n ranging from 500 to 40,000 in increments of 500. To compute the 
NetProphet and PhenoProphet scores of a TF we did not use any information about the 
phenotype or expression profile of the corresponding deletion mutant. 
3.7.7 Network validation 
For Gat201 (CNAG_01551), we used published ChIP data (Chun, Brown, & Madhani, 
2011). For Nrg1 (CNAG_05222) and Usv101 (CNAG_05420) we carried out ChIP-seq as above. 
For each TF, a ChIP-based sequence-specific binding motif was inferred using BioProspector 
(Liu et al. 2001). Promoter regions were defined as the 1,000 bp upstream of the start codon. A 
NetProphet- based binding motif was also inferred by inputting NetProphet’s target confidence 
scores for each TF to FIRE (Elemento, Slonim, & Tavazoie, 2007). The motifs of orthologous 
TFs from S. cerevisiae were obtained from ScerTF (Spivak and Stormo 2012). If the motif for 
the best S. cerevisiae match was unknown the next best match was used. A network of 
interactions that were supported by both ChIP and NetProphet was constructed using the top 
10,000 NetProphet predictions.  
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3.7.8 Transcriptional dynamics of capsule induction 
Triplicate cultures of WT cells were sampled for RNA-seq at 0, 1.5, 3, 8, and 24 h after a 
shift to capsule-inducing conditions. For each gene, a temporal expression signature was 
constructed from its median expression level at each time point. For each pair of genes the 
correlation between their temporal signatures was converted to a dissimilarity. Gene clusters 
were formed by applying hierarchical agglomerative clustering and cutting the resulting 
dendrogram at the 10-branch level. For each cluster, GO and KEGG functional enrichment 
analysis were performed, over-represented terms were examined in detail, and relevant terms 
were selected. The heatmap was created by scaling the expression of each gene to span the range 
from 0 to 1. 
Temporal expression signatures for capsule-involved regulators and capsule-involved 
non-regulators were clustered separately into four groups each (Fig. 3.7.B, circles and boxes, 
respectively). One of the groups of non-regulators is not shown, as we had no comment on it. A 
combined signature was generated for each cluster by taking the median expression level of all 
genes in the cluster at each time point. If the number of NetProphet-predicted activating 
(repressing) edges from one regulator group to another was enriched 1.5-fold relative to an even 
distribution of the activating (repressing) edges among regulator groups then the corresponding 
activating (repressing) edge was shown in Figure 3.7.B. The analogous calculations were made 
for edges from regulator groups to non- regulator groups. 
3.7.9 Data access 
All generated RNA-seq and ChIP-seq data have been submitted to the NCBI Gene Expression 
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE60398. A 
software package that implements PhenoProphet is available at http://mblab.wustl.edu/. 
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Chapter 4: 
Transcriptome Engineering Promotes a 
Fermentative Transcriptional State 
4.1 Abstract 
The rational manipulation of transcriptomes offers the possibility to engineer the cell as a 
collective unit toward specified goals, revolutionizing medicine and bioengineering. Progress in 
transcriptome engineering has primarily consisted of experimental approaches that are iterative, 
slow, and expensive. We have developed a novel algorithm, NetSurgeon, which utilizes genome-
wide gene regulatory networks to identify interventions that will force a cell toward a desired 
expression state. Following extensive in silico validation, we applied NetSurgeon to S. cerevisiae 
biofuel production, generating interventions designed to promote a fermentative state during 
xylose catabolism. Our selected interventions successfully promoted a fermentative 
transcriptional state in the absence of glucose and generated strains with 120% higher xylose 
import rates, improved xylose integration into central carbon metabolism by 303%, and 
increased ethanol production rates by 31%. We conclude by presenting an integrated model of 
transcriptional regulation and metabolic flux that will enable metabolic engineering efforts to 
prioritize functional regulators of central carbon metabolism. 
61 
 
4.2 Background 
The central promise of regulatory systems biology is that a map of the cell’s global 
connectivity will enable us to understand, predict, and rationally manipulate cellular behavior. 
The manipulation of cellular state has many promising applications, including stem cell biology 
and regenerative medicine, biofuel production, and gene therapy. Fundamental progress toward 
the goal of cellular state control has been advanced via systems biology - the study of cellular 
behavior as a complete unit, and synthetic biology - a rapidly advancing discipline which aims to 
design regulatory and effector molecules with defined behaviors. In systems biology, immense 
resources have been invested in genome sequencing, systematic deletion collections, and 
massively parallelized data acquisition, leading to network maps and improved understanding of 
the cell as a complete system (Gerstein, et al., 2012). However, relatively little research has 
focused on using these network models for the prediction and manipulation of cellular behavior 
(Chuang, Hofree, & Ideker, 2010). Synthetic biology has focused on creating molecular 
components that can be placed into a system to modify the transcriptional state of a small 
number of genes. However, genome-scale regulatory engineering is still rare, with most systems 
restricted to a small number of regulators and a limited set of controlled targets (Cameron, 
Bashor, & Collins, 2014). Bridging the gap between these two disciplines, we demonstrate that 
the integration of functional transcriptional network mapping, gene expression profiling, and 
computational modeling can be used to rationally engineer cellular state. 
4.3 Related Work 
Transcriptome engineering focuses on the manipulation of extant cellular networks and 
regulatory systems to enforce a state associated with a desired cellular phenotype. The use of 
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native cellular regulatory mechanisms and network models enables the investigator to access 
evolutionarily optimized states and avoid the extensive iteration often associated with the 
integration of a synthetic regulatory circuit into a host system (Cardinale & Arkin, 2012) 
(Litcofsky, Afeyan, Krom, Khalil, & Collins, 2012). The majority of transcriptome engineering 
thus far has taken place within the context of developmental stem cell engineering, with the 
generation of induced pluripotency being the best example (Takahashi & Yamanaka, 2006). 
Since the development of induced pluripotent stem cells, many transcriptional interventions have 
been identified that move cells at various developmental stages along a specified lineage (Morris 
& Daley, 2013). However, current strategies for direct lineage conversion are often unable to 
fully convert cells to the state of the goal cell fate (Feng et al. 2008; Marro et al. 2011; Morris et 
al. 2014).  
The CellNet algorithm was developed in response to current deficiencies in cellular 
engineering. CellNet is a network-guided algorithm for determining how completely an 
engineered cell recapitulates a target cell state and identifying transcriptional interventions to 
guide further engineering (Cahan et al. 2014). CellNet identifies sub-networks within mouse and 
human cell-type-specific regulatory networks whose expression state is predictive of the cell 
type. These predictive sub-networks are used as features for classifying novel gene expression 
profiles according to the cell type they most resemble. In addition, CellNet selects TF 
interventions for transcriptome engineering by computing a Network Influence Score for each 
TF which is the sum of two components: the dysregulation of the regulator weighted by its 
expression level and the dysregulation of its targets weighted by their expression levels. This 
approach for target selection intervention was used to guide B cell to macrophage conversion by 
knocking down B cell regulators (Morris et al. 2014). The generalizability of this method 
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remains unclear due to the limited number of interventions and evaluations performed. These are 
exciting demonstrations of the power of transcriptome engineering, but studies in these complex 
developmental systems are limited by incomplete transcriptional network maps, complex cell 
culture requirements, and a lack of quantitative phenotypes directly linked to molecular effectors. 
These issues have thus far prevented a quantitative assessment of transcriptome engineering 
efforts. 
4.4 Approach 
In order to quantitatively assess the current state of transcriptome engineering and 
establish benchmarks, we utilized S. cerevisiae as a model system. 196 of the 209 transcription 
factors (TF) with an annotated DNA-binding domain in the S. cerevisiae genome possess a 
known DNA binding specificity (Spivak & Stormo, 2012) (Weirauch, et al., 2014) and the 
genome-wide effect of TF removal on expression has been quantitated through microarray 
profiling (Hu, Killion, & Iyer, 2007) (Kemmeren, et al., 2014). These data provide us with the 
ability to generate an accurate network model and to validate our algorithmic approaches. The 
simplicity of S. cerevisiae culture enables quantitative modeling and assessment, with the 
input/output metabolic function measurable by HPLC and the transcriptional state of the cell 
quantitated by RNA sequencing. 
We identified the industrially relevant fermentation of the pentose carbohydrate xylose as 
a prototype application that met all our criteria for the quantitative assessment of transcriptome 
engineering. Xylose is a component of hemicellulose, a polymer that represents approximately 
23% of lignocellulosic biomass and is not efficiently fermented by S. cerevisiae into ethanol 
(Chandel & Singh, 2011). Biochemical research has identified all enzymes required for the 
integration of xylose into the cell’s central carbon metabolism. However, recombinant yeast 
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strains expressing these enzymes, and grown in mixed glucose/xylose cultures, rapidly ferment 
all available glucose and then undergo a diauxic shift into a respiratory metabolic state. 
Salusjarvi et al demonstrated through transcriptional and proteomic analysis that cells grown on 
xylose exist in a hybrid fermentative/respiratory state (Salusjärvi, et al., 2008). The abundance of 
systems-level data, known metabolic pathways, clear regulatory constraint and quantitative 
phenotypes enabled us to utilize the transcriptome engineering of xylose metabolism to evaluate 
the current state of transcriptome engineering. 
In this work we present a novel algorithm, NetSurgeon, designed to enable transcriptome 
engineering. We ran this algorithm over genome-wide gene regulatory networks (GRN) 
generated using NetProphet (Haynes et al., 2013), and assessed its performance at selecting TFs 
whose deletion or overexpression will move the transcriptional state of the cell toward a desired 
goal. Following algorithmic validation, we applied the algorithm to engineer a fermentative 
xylose transcriptional state and assessed global cellular response to our transcriptional 
interventions by using analytical chemistry. Our results demonstrate that transcriptome 
engineering can be efficiently guided using network models and reveal the degree of 
transcriptional control over a quantitative multi-factorial phenotype. 
Our transcriptome engineering method, NetSurgeon, simulates interventions on a 
transcriptional network model to prioritize those that are likely to move the transcriptional state 
towards a goal state. Our transcriptome engineering efforts consisted of three steps. First, a map 
of the network of direct, functional regulation is built (Fig. 4.1.A). Second, starting and goal 
transcriptional states are defined and our algorithm for prioritizing TF interventions, NetSurgeon, 
searches through the all possible interventions (deletion or overexpression) to identify 
interventions that are likely to move the transcriptional state towards the goal state (Fig. 4.1.B). 
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Finally, strains containing the predicted best interventions are created and RNA-seq and HPLC 
are used to quantitatively assay their transcriptional and metabolic state (Fig. 4.1.C). 
Figure 4.1. Overview of the computational and experimental approaches for rational control of transcriptional state. 
Panel A: Approach for generation of a gene regulatory network model from DNA binding specificity information 
and gene expression profiling. Panel B: Approach for target selection through intervention simulation and regulator 
prioritization. Panel C: Approach for quantitative assessment of intervention effect via RNA sequencing and HPLC 
metabolite profiling and modeling. 
We built an integrated gene regulatory network map by building and combining separate 
functional and physical maps. The functional map was itself constructed by combining maps 
inferred by NetProphet from three large expression datasets (Chua, et al., 2006) (Gasch, et al., 
2000) (Hu, Killion, & Iyer, 2007). NetProphet is a state-of-the-art GRN mapping algorithm that 
combines a differential expression (DE) analysis and a co-expression analysis. The physical map 
was built using a combination of TF binding information from both chromatin 
immunoprecipitation (ChIP) implicated TF target interactions (Abdulrehman, et al., 2010) 
(Balaji, Babu, Iyer, Luscombe, & Aravind, 2006) (Harbison, et al., 2004) (Lee, et al., 2002) and 
TF binding potential estimated by scanning a collection of position weight matrix (PWM) 
models over all yeast promoters (Spivak & Stormo, 2012). An integrated functional and physical 
GRN map was built by assigning a score to each TF-target gene pair that was equal to the 
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geometric mean of the scores assigned to it in the functional and physical networks. The 
geometric mean ensures that high scoring interactions are supported by both binding and 
expression evidence. 
To select interventions that will shift transcriptional state toward the goal state, we 
applied NetSurgeon. This algorithm assigns a score to each possible intervention representing its 
confidence that the intervention will yield a shift toward the goal state. The score assigned to 
each intervention is based on the number of targets of the regulator that are predicted to move 
toward the goal state and degree to which the initial and goal states differ for the regulator and 
targets. Deletion of a TF is predicted to increase expression targets it represses and decrease 
expression of targets it activates. Conversely, overexpression of a TF is predicted to decrease 
expression targets that the TF represses it and increase expression targets it activates. High-
scoring interventions are those that are predicted to change many genes in the right direction, 
with greater weight given to targets that are the most significantly differentially expressed genes 
between the initial state and goal state. 
4.5 Results 
4.5.1 Network models can efficiently guide transcriptome engineering efforts 
To assess the ability of NetSurgeon to select interventions that will move the initial 
transcriptional state toward the goal state, we used NetSurgeon to select regulator interventions 
for single regulator intervention goal states from publically available gene expression datasets. 
We choose to use independent single regulator intervention expression profiles for validation 
goal states, rather than randomly generated expression states, because randomly generated 
expression states may not be biologically achievable. We constructed the GRN used for 
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validation in a similar fashion as previously described, except the functional network was 
inferred from only one of the three gene expression datasets previously used, the dataset 
consisting of 269 regulator deletions strains grown in YPD (Hu, Killion, & Iyer, 2007). 
We initially examined NetSurgeon’s performance on goal states that we knew could be 
achieved by a single TF deletion mutant growing in synthetic complete medium (SC). This 
medium was different from the rich medium (YPD) in which the expression profiles used to 
build the network were obtained, but the two media featured the same sugar: 2% glucose. The 
goal states were an independent set of expression profiles from regulator deletion mutants 
(Kemmeren, et al., 2014). For each of the 245 goal states, NetSurgeon used the 
NetProphet+PWM network to assign scores to all 320 possible regulator deletions. We plotted 
the number of goal states for which NetSurgeon ranked the best intervention (the one that 
actually produced the goal state profile) at or above each rank (Fig 4.2.A, green). We compared 
this to a random assignment of rankings for each of the deletion goal states, by running 
NetSurgeon on 100 random networks of the same topology (Fig. 4.2.A, gray). We found that 
NetSurgeon is able to assign higher scores to the correct interventions compared with ranks 
assigned by running NetSurgeon over randomly generated networks (Mann-Whitney U test P < 
10-46). Further, we observed that NetSurgeon performed at random chance levels using the 
permuted networks, indicating network structural accuracy is critical for NetSurgeon 
performance. We also assessed the ability of NetSurgeon to identify the best intervention within 
the top 5 scoring interventions, a reasonable number of interventions to test experimentally. 
NetSurgeon ranks the best intervention in the top 5 for 91 goal states, which is 29-times better 
than random networks scores (P<10-165). 
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Figure 4.2.A. In silico assessment of NetSurgeon using 245 deletion mutant expression profiles grown in synthetic 
complete medium. Plotted curves show the number of goal states for which NetSurgeon ranked the best intervention 
at or above each rank (green), compared with random ranks (gray). 
We also evaluated the ability of NetSurgeon to indentify interventions in cells cultured in 
conditions even further from those used to construct the GRN. The goal states consisted of 63 
expression profiles obtained from regulator overexpression strains grown in selective synthetic 
medium supplemented with 2% galactose (Chua, et al., 2006). We assessed the scores assigned 
to the best regulator for each overexpression goal state and compared the outcome to scores 
generated using random networks (Fig. 4.2.B). We found that NetSurgeon is able to assign 
higher scores to the correct interventions compared with random network generated scores 
(Mann-Whitney U test P < 10-6). NetSurgeon is also able to assign the best intervention a top 5 
rank for 8 of the 63 goal states (13%), a 10 fold improvement over the mean of the random 
network 
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Figure 4.2.B. In silico assessment of NetSurgeon using 63 overexpression strains grown in grown in selective 
synthetic medium supplemented with 2% galactose. Plotted curves show the number of goal states for which 
NetSurgeon ranked the best intervention at or above each rank (green), compared with random ranks (gray). 
In order to evaluate the effect of network accuracy on NetSurgeon performance, we 
applied NetSurgeon to GRNs inferred from the same expression data sets by CLR (Faith, et al., 
2007), regression (Bonneau, et al., 2006), NetProphet (Haynes, et al., 2013), and NetProphet 
integrated with PWM scores. We first evaluated the structural accuracy of the five GRNs by 
determining the level of ChIP support for high confidence interactions in each GRN. We then 
evaluated the performance of NetSurgeon when using each of these five GRNs on our two test 
data sets: the TF-deletion in SC glucose and TF-overexpression in SC galactose. We plotted the 
structural accuracy of each of the five GRNs against the NetSurgeon’s accuracy when using that 
GRN (Fig. 4.2.C). We observed a clear pattern of improved NetSurgeon performance with more 
structurally accurate GRNs. A level-log regression model was fit to test this observation 
(Multiple R2 = 0.853, P=0.00014) and forecasted a maximum NetSurgeon intervention recovery 
of 0.85 AUC with a perfect network model, which is a 33% improvement over current 
NetSurgeon performance. 
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Figure 4.2.C. In silico assessment of the effect of network structural accuracy on NetSurgeon target intervention 
selection accuracy. Network structural accuracy of five GRNs, summarized by area under the precision recall curve 
at 5% ChIP recovery (x-axis), is compared with NetSurgeon intervention target selection accuracy, summarized by 
area under the curve of the number of goal states for which NetSurgeon ranked the best intervention at or above 
each rank (y-axis). Gray dotted lines indicate chance 5% ChIP recovery AUC and cell state selection AUC.  
To assess the practicality of NetSurgeon-guided engineering, we ran NetSurgeon on the 
NetProphet+PWM network and computed the median number of interventions needed to identify 
the first, the best, and all deletion genotypes that reduce the distance between the wild-type cells 
and the goal by at least 10% (Fig. 4.2.D). A median of 12, 22 and 51 mutant strains were 
required to recover the first, the best, and all interventions (10-, 7-, and 4-fold better than 
random, respectively). 
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Figure 4.2.D. In silico assessment of the median number of NetSurgeon interventions required to generate any 
strain, the best strain, or all strains, that will converge expression state at least 10% towards the goal state (green), 
compared with random ranking (gray). 
4.5.2 Application of transcriptome engineering to biofuel production 
Following the successful in silico validation of our approach for transcriptome 
engineering, we applied the algorithm to the industrially relevant problem of ethanol production 
in a mixed glucose-xylose co-culture. Principle components analysis of RNA-seq data from S. 
cerevisiae cells grown with xylose as the sole carbon source indicated that the system was in a 
hybrid transcriptional state with some characteristics of cells grown in 2% glucose, a 
fermentative state, and some characteristics of cells grown in 1.3% ethanol, a respiratory state 
(Fig. 4.3.A). As S. cerevisiae cells do not natively consume xylose, we hypothesized that the 
system was unable to recognize the pentose carbohydrate as a fermentable carbon source and 
therefore entered into a transcriptional state that was non-optimal for fermentative metabolism. 
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Figure 4.3.A. Principal component analysis of RNA expression profiles reveals a state transition between cells 
grown on 5% glucose (green), 5% xylose (blue), and 1.3% ethanol (red). 
We therefore sought to identify interventions that would shift the system from the xylose-
only transcriptional state (origin state) to the high-glucose state (goal state). In order to apply 
NetSurgeon to this problem, we generated the integrative, genome-wide network map described 
above. Using this map, NetSurgeon produced a rank-ordered list of regulators whose deletion 
was predicted to force the system toward the 2% glucose transcriptional state. From this rank 
ordered list, we selected the top eight predicted interventions for biological validation via PCR-
mediated genetic deletion of the selected regulators in the H2217-7 yeast strain (Table 4.1). In 
order to assess the combinatoric effect of the predicted deletions, we generated an additional 
three strains carrying deletions in two of the NetSurgeon-selected regulators (cat8/hap4, 
cat8/adr1, cat8/aft2). For a limited comparison of our algorithmically selected deletions with 
expert intuition, we deleted the master regulator SNF1, the yeast ortholog of AMP kinase and a 
critical regulator responsible for glucose repression and other features of fermentative 
metabolism. 
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WILD-TYPE SINGLE KO DOUBLE KO 
H2217-7 snf1 cat8/adr1 
 adr1 cat8/hap4 
 cat8 cat8/aft2 
 usv1  
 gis1  
 msn2  
 hap4  
 msn4  
 aft2  
Table 4.1. Wild-type and deletion mutant strains profiled 
We found that the NetSurgeon-selected targets were supported by existing literature. Cat8 
and Hap4 are respiratory factors active in the general cellular response to xylose and deletion of 
HAP4 was recently shown to improve cellobiose consumption rates (Salusjärvi, et al., 2008) 
(Lin, et al., 2014). MSN2 and MSN4, encoding stress associated factors, were observed to be 
highly upregulated in xylose and their transcriptional targets misregulated (Matsushika, 
Goshima, Hoshino, & others, 2014). Usv1, Gis1 and Aft2 were all found to have clear roles in 
the yeast transcriptional response to non-fermentable carbon sources and general stress response 
(Hlynialuk, Schierholtz, Vernooy, & der, 2008) (Pedruzzi, Bürckert, Egger, & Virgilio, 2000) 
(Blaiseau, Lesuisse, & Camadro, 2001). 
Aerobic batch fermentations were used to assess the outcome of our transcriptome 
interventions at the transcriptional and metabolic levels. Cells were inoculated into synthetic 
complete medium supplemented with 2% glucose and 5% xylose at an OD600 of 1.0+/- 0.2 and 
grown for 48 hours. Samples were taken for RNA-sequencing at 4 hours and 24 hours, 
representative of the glucose-xylose and xylose-only metabolic states. Aliquots were acquired for 
74 
 
HPLC metabolite analysis across the 48 hour fermentation (Fig. 4.3.B). Using this data, we 
examined the NetSurgeon’s ability to control transcriptional state and quantitatively assessed the 
effect of transcriptome transcriptional state change on a complex phenotype. 
 
Figure 4.3.B. Top: Glucose (light blue), xylose (dark blue), and ethanol (red) metabolite concentration profiles from 
the fermentation of the wild-type H2217-7. Bottom: Overview of RNA-seq (magenta) and HPLC (turquoise) 
sampling strategy for aerobic batch fermentations used in this study.  
4.5.3 Transcriptome engineering successfully promotes a fermentative state: 
Differential expression analysis revealed that 2,887 genes are differentially expressed by 
at least two fold in wild-type cells as a result of glucose depletion (42% of all genes. Fig. 4.4.A). 
Six of the eight NetSurgeon-selected interventions lowered the number of differentially 
expressed genes. The cat8 mutant was the best, preventing the change in expression of 1,182 of 
2,887 DE genes while creating only 526 new DE genes, for a net reduction of 656 DE genes. 
Notably, the deletion of CAT8 reduced differential expression better than the deletion of SNF1, a 
master regulator of the S. cerevisiae glucose repression system. 
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Figure 4.4.A. Number of 2-fold or greater differentially expressed genes between the wild-type strain in the 
fermentative state and each strain in the respiratory state. Green and red bars indicate strains with less and more 
differentially expressed genes than wild-type respectively. 
Next, we calculated the Euclidean distance between the wild-type expression state in the 
glucose-xylose phase and the deletion strain’s expression state in the xylose-only phase (Fig. 
4.4.B). Six of the eight NetSurgeon interventions lowered the Euclidean distance between the 
two phases. The single deletion mutant cat8 reduced the genome-wide expression distance 
between the glucose-xylose phase and the xylose-only phase by 28.4%. The mean reduction in 
Euclidean distance of the six successful NetSurgeon selected interventions was 20.8%. As in the 
DE analysis, the deletion of HAP4 and ADR1 increased the total distance between the two state 
vectors. 
76 
 
 
Figure 4.4.B. Euclidean distance between the full expression profile of wild-type strain in the fermentative state, and 
the full expression profiles of all strains in the respiratory state. Green and red indicate reduced and increased 
Euclidean distance compared with wild-type respectively. 
The NetSurgeon-selected interventions were specifically targeted at optimizing the 
expression state of 445 genes involved in carbon metabolism. Among these 445 genes, the cat8 
deletion mutant reduced the Euclidean distance by 36% (Fig. 4C). On average, the six successful 
NetSurgeon-selected interventions reduced the Euclidean distance between the two state vectors 
by 24%. 
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Figure 4.4.C. Euclidean distance between the expression 445 metabolically active computationally optimized genes 
in the fermentative state of the wild-type strain, and the matching optimized gene expression profiles of all strains in 
the respiratory state. Green and red indicate reduced and increased Euclidean distance compared with wild-type 
respectively. 
Each of the eight NetSurgeon selected transcription factors had known roles in the 
regulation of the cellular stress response or respiratory processes. We evaluated the ability of 
each transcription factor to promote a fermentative state across specific metabolic pathways (Fig 
4.4.D). With the exception of adr1, each deletion mutant affected the expression of genes across 
many of the metabolic pathways in central carbon metabolism. Seven of the eight NetSurgeon-
selected interventions lowered the Euclidean distance in at least one of the central carbon 
metabolism pathways evaluated. All six of the interventions that reduced differential expression 
and global Euclidean distance moved the expression of glycolytic genes toward a fermentative 
state.  
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Figure 4.4.D. Euclidean distance between the expression profiles of central carbon metabolic pathways in the 
fermentative state of the wild-type strain, and the matching central carbon metabolic pathway expression profiles of 
all strains in the respiratory state. Green and red indicate reduced and increased Euclidean distance compared with 
wild-type respectively. 
Three of these interventions shifted the expression of TCA cycle genes toward a 
fermentative state. Deletion of CAT8 promoted a fermentative state in many metabolic pathways 
essential for xylose fermentation, including genes involved in glucose utilization, the pentose 
phosphate pathway, glycolysis, the TCA cycle, and acetate/glycerol production. All of the TCA 
cycle genes were moved toward the expression level associated with fermentative metabolism 
(Fig 4.4.E). Deletion of CAT8 also reduced the Euclidean distance of all TCA genes from the 
fermentative state by 60%. These observations highlight the power of transcriptome level 
interventions to modulate the expression of many more genes than is feasible by traditional, one-
gene-at-a-time genetic engineering.  
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Figure 4.4.E. Comparison of the expression TCA cycle genes between the fermentative state of the wild-type strain 
(red), the respiratory state of the wild-type strain (green), and the respiratory state of the cat8 deletion mutant strain 
(blue). 
4.5.4 Identification of transcriptional states associated with improved 
fermentation 
In order to assess the change in cellular metabolic behavior following our transcriptional 
interventions, we profiled metabolic intake and output via HPLC. HPLC analysis identified three 
metabolic states associated with high glucose, low glucose, and respiratory metabolic phases. We 
focused our downstream analyses on the high glucose and respiratory phases of the fermentation 
during which we had carried out RNA-seq.  
To examine the ability of the selected transcriptional interventions to control the 
metabolic state of the cell, we calculated the percentage of input carbon that end up in each of 
the major carbon fates in each phase (Fig 4.5.A, 4.5.B). Carbon import rates significantly 
declined in the absence of high glucose, with a mean reduction of import across all assayed 
genotypes by 86%. In addition to changes in import rate, the cells significantly upregulated their 
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commitment of carbon to respiratory processes in the xylose-only phase. Carbon commitment to 
respiration changed from a mean of 24% in the glucose-xylose phase to 89% in the xylose-only 
phase. This indicated that the metabolism of all strains had shifted into a respiratory mode during 
the xylose-only phase (Fig. 4.5.B). 
 
Figure 4.5.A-B. Transcriptome interventions alter carbon intake rates, but do not prevent a transition to a respiratory 
metabolism. Panel A: Cellular metabolic input and output across profiled genotypes during the glucose-xylose phase 
of aerobic fermentation. Panel B: Cellular metabolic input and output within the xylose phase. 
Although the tested interventions did not prevent the transition to a respiratory metabolic 
state, they did affect the cell’s commitment of carbon to output metabolites significantly. We 
observed 41 statistically significant changes in carbon commitment across the 13 profiled 
genotypes (p<0.05, t-test, Benjamini-Hochberg corrected). 28 of these changes were within the 
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glucose-xylose phase. Carbon commitment to all of the profiled metabolites and phenotypes was 
altered in at least one of our transcriptional interventions, indicating that changes in 
transcriptional state have the power to impact all dimensions of cellular metabolism. Carbon 
commitment to xylitol was significantly increased in transcriptional interventions associated with 
respiratory processes, a potential side effect of the respiratory factors modulating the ratio of the 
Xyl1, Xyl2, and Xks1 enzymes required for xylose integration into central carbon metabolism. 
Interestingly, all significant changes in carbon commitment to ethanol and biomass were 
reductions. The deletion of SNF1, HAP4, USV1, GIS1, MSN4 and AFT1 significantly reduced 
carbon commitment to ethanol, with a mean reduction in carbon flux by 26%. Deletions 
involving CAT8 or HAP4 significantly reduced carbon commitment to biomass by 33% and 
38%, respectively, in the glucose-xylose phase of the fermentation.  
We also observed 57 statistically significant changes in the specific rates of metabolite 
production or consumption across the glucose-xylose and xylose-only phases of the fermentation 
(p < 0.05, t-test, Benjamini-Hochberg corrected). Within the glucose-xylose phase, we identified 
industrially relevant changes in glucose and xylose consumption rates, acetic acid output and 
ethanol production. All of the profiled interventions on respiratory regulators (cat8, hap4, adr1) 
improved the specific rate of glucose consumption between 11% and 40% (Fig. 4.5.C). We 
found that hap4 and msn4 mutants improved the specific rate of xylose consumption by 170% 
and 120% respectively (Fig. 4.5.D). Acetic acid, a fermentation byproduct demonstrated to 
inhibit glycolysis, was also produced at 53%-83% lower specific rates in the hap4 and cat8 
mutants (Fig. 4.5.E) (Pampulha & Loureiro-Dias, 1990). Importantly, the specific rate of ethanol 
production was significantly increased by 22% and 31% in the cat8 and hap4 mutants (Fig 
4.5.F). Within the set of stress associated factors, we found that the deletion of USV1, MSN2, 
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MSN4 and AFT2 significantly reduced the specific rate of ethanol production, with a mean rate 
reduction of 22% (Fig 4.5.F). Taken together, these data demonstrate the ability of transcriptome 
engineering to generate significant changes in cellular behavior, even in the absence of complete 
phenotypic conversion. 
 
Figure 4.5.C-F. Transcriptome interventions alter specific rates of metabolite production or consumption in the 
glucose-xylose phase. Panel C: Specific rate of glucose consumption. Panel D: Specific rate of xylose consumption. 
Panel E: Specific rate of acetic acid production. Panel F: Specific rate of ethanol production. 
4.5.5 An integrated model of transcriptional regulation and metabolic flux 
The lack of data linking transcriptional state with metabolic phenotypes has prevented the 
use of transcriptional interventions for effective engineering of metabolism. In order to address 
this issue, we utilized our dataset to construct an integrated model of S. cerevisiae central carbon 
metabolic flux and expression. We identified regulators linked to flux by correlating their 
expression with pathway carbon flux. From this set of regulator-flux correlations, we identified 
regulators putatively controlling metabolic flux outcomes via network-predicted direct regulatory 
relationships (Fig. 4.6). 
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Figure 4.6. An integrated map relating transcription factors to central carbon metabolism flux. Blue rounded 
rectangles: pathways in central carbon metabolism. Green ovals: transcription factors. Links between transcription 
factors and pathways denotes transcription factor expression correlation with increased (black arrow headed link) or 
decreased (red circle headed link) flux through the pathway. Solid link lines: transcription factor directly regulates 
the expression of genes in the pathway. 
This analysis revealed that three transcriptional regulators were deeply interconnected 
with biochemical pathways important for xylose metabolism and fermentation. CAT8 expression 
was correlated with genes associated with xylose utilization, the pentose phosphate pathway, 
acetate production and the TCA cycle. Msn4 was predicted to directly regulate genes involved in 
xylose utilization, the pentose phosphate pathway, and the TCA cycle, and flux through these 
pathways was anti-correlated with MSN4 expression. Pdr3 was revealed to be a regulator of 
glycolytic genes, and flux through these pathways was positively correlated with PDR3 
expression. This integrated model of transcriptional regulation and metabolic flux is an important 
step toward the rational engineering of S. cerevisiae metabolism. 
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4.6 Discussion 
We have demonstrated that transcriptional network maps can be used to rationally 
manipulate cellular state by identifying the crucial regulators mediating a state transition and 
prioritizing them for genetic intervention. The formalization of this process of rational state 
manipulation is expected to enable future developments in personalized medicine, improve 
approaches to stem cell engineering, and reduce the costs associated with these efforts. Our work 
establishes quantitative benchmarks in this new field, enabling the rapid progress generally 
associated with clear benchmarks (Stolovitzky, Monroe, & Califano, 2007). 
The availability of deletion and overexpression collections in S. cerevisiae has enabled us 
to assess the state of the art in network-guided transcriptome engineering. We found that 
NetSurgeon can identify the best intervention within a median of 22 guesses, a 7-fold 
improvement over random guessing. We observed that network amps built from data on one 
environmental condition can be successfully used to predict interventions in different conditions. 
This is important for applications that deviate from standard environmental conditions. Finally, 
we have demonstrated the utility of TF-network maps enriched with direct regulatory 
relationships; maps generated by NetProphet together with PWM models led to selections that 
were substantially better than those made by using maps expression correlation or CLR.  
We applied NetSurgeon to optimizing yeast for ethanol production from glucose-xylose 
co-culture. NetSurgeon selected critical regulators highlighted in the literature and six of the 
eight promoted a fermentative transcriptional state. Although the single deletions were 
insufficient to entirely prevent a state transition involving 43% of the yeast genome, it succeeded 
in significantly changing the rate and ratio of cellular carbon commitment. We found that 
regulators associated with respiratory processes had significant metabolic effects in the 
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fermentative phase of the culture. We also found that deletion of transcription factors controlling 
stress response lowers the rate of production and the total ethanol yield. In addition, our dataset 
of 8,055 metabolic measurements with 73 matched RNA sequencing profiles across 14 
genotypes will enable future engineering efforts to identify and rationally manipulate the critical 
regulators of metabolic flux in order to maximize biofuel production. 
One of the advantages of transcriptome engineering is the possibility of accessing 
evolutionarily optimized states associated with specific phenotypes. The expression levels of 
genes within linear metabolic pathways such as glycolysis and the TCA cycle are highly 
regulated in order to maintain a correct ratio of enzyme products necessary for avoiding 
intermediate metabolite accumulation and allosteric inhibition of upstream processes. The 
engineering of optimal expression levels across entire pathways is a challenging problem that is 
often addressed through iterative selection strategies (Wang, et al., 2009). We observed that 
manipulation of regulator expression levels is a promising strategy to access pre-defined 
expression states across entire pathways. The effect of CAT8 deletion on TCA gene expression is 
one example of an interventions reconfiguring the expression of an entire pathway toward a 
fermentative state. The TCA cycle within S. cerevisiae consists of twenty-six genes, making 
optimization of this pathway’s expression level a difficult task through one-gene-at-a-time 
engineering. Cat8 was predicted by NetProphet to regulate four genes within the TCA cycle and 
the glyoxylate pathway, and removal of this factor was predicted to move the TCA cycle toward 
a fermentative expression configuration. We found that CAT8 deletion moved all twenty-six 
genes of the TCA cycle toward a fermentative state, providing evidence that naturally evolved 
transcriptional states can be leveraged for transcriptome engineering. 
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Our analysis of the double deletion strains highlighted the complexity of epistatic effects 
within gene regulatory networks. Although the generation of strains with multiple regulatory 
perturbations offers the possibility of large scale reconfiguration of cellular state, we observed 
that the three double deletion strains failed to reduce differential expression and Euclidean 
distance as much as their component single deletions. This non-additivity between genotypes 
indicates that a more sophisticated approach to modeling the effect of multiple regulator 
perturbations will be required to expand target selection approaches multiple perturbations. 
4.7 Methods 
4.7.1 Network guided target selection 
To rank possible regulator interventions for convergence towards a goal expression state, 
NetSurgeon uses a GRN to simulate interventions for all regulators, and for each simulated 
regulator intervention a score is assigned representing the confidence that the regulator 
intervention will converge the expression state towards the goal state. The score for a simulated 
regulator intervention is based on the enrichment of the regulator’s simulated intervention effects 
to fix the total dysregulation of all genes between the initial and goal expression states, where the 
total dysregulation of all genes is quantified by the sum of the negative log pvals of significance 
of differential expression. Specifically the NetSurgeon network intervention score for a regulator 
is: 
NetSurgeon network intervention score (Ri) = max( -log10 ( hypergeometric distribution(Xij * 
(W/D), W, U-W, (Xij+Yij) * (W/D) + Cij - Zij))) for network cutoff j = 500, …, 40,000 
where U is the total number of genes in the network, W is the number of dysregulated genes, D 
is total amount of dysregulation, Xij is the total amount of dysregulation that the intervention of 
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regulator Ri will remove when considering only the top j interactions in the network, Yij is the 
total amount of dysregulation that the intervention of regulator Ri will make worse when 
considering only the top j interactions in the network, Cij is the total number of genes regulated 
by regulator Ri when considering only the top j interactions in the network, and Zij is the total 
number of dysregulated genes regulated by regulator Ri when considering only the top j 
interactions in the network. 
4.7.2 Strain engineering 
The xylose metabolizing strain VTT-C-99318 (CEN.PK2-1D ura3::XYL1 XYL2 
his3::XKS1 kanMX) was acquired from Salusjarvi et al. and used as the base strain for all 
experiments in this study (Salusjärvi, et al., 2008). The At5g17010 xylose transporter from A. 
thaliana was transformed into the VTT-C-99318 strain and maintained through the use of 
dropout media (Hector, Qureshi, Hughes, & Cotta, 2008). The genetic deletion of algorithmically 
selected transcription factors was accomplished through PCR amplification and targeting of drug 
cassettes to the selected ORF via the addition of 45 base pairs of homologous sequence to the 
5’/3’ amplifying oligos (Baudin, Ozier-Kalogeropoulos, Denouel, Lacroute, & Cullin, 1993). 
Prior to use in experimentation, all strains were freshly plated onto selectable media from frozen 
stocks. 
4.7.3 S. cerevisiae fermentations 
All S. cerevisiae strains were grown aerobically in 60 mL of synthetic complete at 30℃ 
in 250 mL baffled erlenmeyer culture flask shaken at 225 RPM. Cultures for identification of 
differential expression associated with carbon sources were grown in triplicate in either 50 g/L 
glucose, 50 g/L xylose or 1.3 g/L ethanol for 8 hours prior to collection of biomass for RNA 
sequencing. Culture of cells for evaluation of the impact of transcriptional interventions were 
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performed in triplicate and initiated by inoculating 1.0+/- 0.2 OD600 units of biomass into 60 
mL of synthetic complete media supplemented with 20 g/L glucose and 50 g/L xylose. Samples 
taken for RNA-seq analysis were aliquoted from the primary culture, spun down at 3000xg and 
frozen in liquid nitrogen prior to downstream analysis. The supernatant of samples for HPLC 
was collected by centrifugation of culture samples at 12,000xg for 3 minutes prior to snap 
freezing for storage in a dry ice/ethanol bath. All samples were stored at -80℃. At least two 
independent experiments of three biological replicates was performed for each genotype 
evaluated by HPLC. Cellular density was quantitated through analysis of culture turbidity at 600 
nm. 
4.7.4 Metabolite analysis 
The concentration of input and output cellular metabolites was analyzed using HPLC. 
Supernatant solutions were stored at -80℃ and filtered through the use of 0.22 um syringe prior 
to HPLC analysis. Metabolites were eluted from an Aminex HPX-87H column maintained at 
65℃ and peaks detected by refractive index. Identified peaks were quantified through integration 
and interpolated against serial dilutions of standards for glucose, xylose, xylitol, glycerol, acetic 
acid and ethanol. Analysis of HPLC data was performed on a per biological replicate basis, with 
metabolic input/output relationships quantified across each fermentation and pooled into a single 
distribution based on genotype. Turbidity measurements were converted into units of g/biomass 
based on the turbidity to biomass conversion factor published (Hector, Qureshi, Hughes, & 
Cotta, 2008). Calculations of analyte rate and specific rate of change were performed across 
steady states identified in the ethanol dimension. In order to evaluate internal carbon flux, a 
system of linear equations was developed to describe central carbon metabolism in S. cerevisiae. 
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The system of equations was fit to experimentally measured parameters of carbon import and 
export for each genotype across the glucose/xylose and xylose-only phases of each fermentation. 
4.7.5 RNA sequencing and analysis 
Total mRNA was isolated using the yeast RiboPure kit (Life Technologies, Carlsbad 
CA). Libraries for RNA-Seq were prepared as in (Haynes, et al., 2011). Briefly, poly(A) RNA 
was selected from the total RNA isolated as above using the mRNA Catcher Plus Kit (Life 
Technologies) with an epMotion 5075 automated pipettor (Eppendorf). The poly(A) RNA was 
subsequently sheared by incubating in TURBO DNA-free buffer at 75°C for 10 minutes and 
purified with the QIAquick PCR Purification Kit (Qiagen). First strand cDNA synthesis was 
performed using random hexameric primers and SuperScript III Reverse Transcriptase, followed 
by treatment with E. coli DNA ligase, DNA polymerase I, and RNase H for second-strand 
synthesis, all using standard methods. The cDNA libraries were end-repaired with a Quick 
Blunting kit and A-tailed using Klenow exo- with dATP (New England Biolabs). Illumina 
adapters were ligated to the cDNA and fragments ranging from 150-250 bp in size were selected 
using gel electrophoresis. The libraries were enriched and indexed in a 10-cycle PCR using 
Phusion Hot Start II High-Fidelity DNA (Fermentas), purified, and pooled in equimolar ratios 
for multiplex sequencing on an Illumina HiSeq 2500. 
4.7.6 RNA/metabolic data integration and analysis 
We utilized two different complementary methods for integrating RNA expression 
profiles and metabolic data in order to gain a better understanding of the molecular mechanisms 
controlling metabolic phenotypes. First, we used the limma software package (Ritchie, et al., 
2015) to identify differentially expressed genes within the fermentative and respiratory states 
between the wild-type strain and each deletion strain. We then used this differential expression 
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analysis to putatively link genes mechanistically to metabolic analyte outcomes by identifying 
differentially expressed genes in metabolic pathways linked to each metabolic analyte. 
In addition to differential expression analysis, we also identified genes linked to 
metabolic outcomes by identifying genes whose expression significantly correlates with carbon 
flux. For each gene and each metabolic pathway we computed the Pearson correlation coefficient 
between the gene’s expression profile, and the computed carbon flux through the pathway. We 
then generated a null distribution of correlation coefficients between gene expression and 
pathway flux by randomly generating 10,000 expression vectors by sampling per condition from 
the expression of all genes within the condition with replacement. These null distributions of 
expression correlation with pathway flux were then used to assign false discovery rate corrected 
p-values to the significance of each gene’s expression correlation with flux measurements of a 
metabolic pathway.  
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Chapter 5: 
Discussion 
5.1 Conclusion 
The central promise of Systems Biology is that a map of the cell’s global connectivity will 
lead to the ability to understand, predict and manipulate cellular behavior in a rational fashion. 
With the advent of high throughput experimental approaches to assay gene expression state, and 
subsequent computational methods to infer gene regulatory network structure over the past 15 
yeas, our ability to measure and model cellular decision making has improved greatly. However, 
to truly reach the goal of rational engineering of cellular state, transcriptional network models 
must have the capacity to predict expression and physiological phenotype state in novel 
conditions. This dissertation examined and applied strategies to utilize the predictive power of 
gene network models to guide experimental and engineering efforts. 
In chapter 2 we identified the need for improved causative regulatory network models, and 
then integrated expression based functional interaction evidence and TF binding based physical 
interaction evidence, in order to utilize the full predictive power of gene network models. These 
causative network models are vital to understanding the information flow through the network, 
which allows for expression prediction and cellular engineering. In response, we developed a 
method to enrich the most confident edges of an inferred network model with edges that are 
supported by functional and physical evidence. This method combines the strengths of multiple 
approaches to network building by iterating between expression based network building, and de 
novo inference of TF binding specificity using the network interactions and protein homology. 
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We applied this approach to infer the Saccharomyces cerevisiae and Cryptococcus neoformans 
regulatory networks and TF binding motifs and, in Cryptococcus neoformans, we were able to 
identify 18 TF binding motifs, of which 15 are novel. 
In Chapter 3, we inferred a model of the regulatory network in Cryptococcus neoformans 
controlling the fungal pathogen’s capsule and we utilized this network to generate physiological 
phenotype predictions which guided further experimentation. The integrated analysis pipeline 
presented in this chapter demonstrates the power of regulatory networks to predict phenotypes 
and guide experimental efforts; this approach allowed us to identify 16 novel regulators 
controlling the capsule, which is a substantial improvement from the 11 previously known 
regulators. Also, we used the final network model to gain a better understanding of cryptococcal 
capsule biology through analysis of regulation of the enzymes and transporters responsible for 
biosynthesis of capsule sugars and modeling the dynamics of capsule induction. 
In Chapter 4, we investigated the power of causative regulatory networks to guide a real 
cellular engineering application. To facilitate engineering efforts we presented a novel algorithm, 
NetSurgeon, which scores simulated overexpression and deletion interventions based on the 
confidence that each intervention will move the expression state towards a desired goal state. We 
validated our algorithm through extensive in silico testing using existing large publically 
available expression profiling datasets of deletion and overexpression regulator interventions in 
S. cerevisiae. Then, we applied our NetSurgeon method to engineer S. cerevisiae strains with 
improved biofuel production. NetSurgeon selected 8 TF deletion strains predicted to promote a 
fermentative transcriptional state, normally occurring in a glucose-rich medium, in an 
environment containing only the alternative carbon source xylose. We found that 6 of the 8 TF 
deletion strains successfully moved the transcriptional state of xylose-consuming cells toward a 
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fermentative state. In addition, we observed improved industrially relevant metabolic phenotypes 
in several of our intervention strains including 120% higher xylose import rates and 31% 
increased ethanol production rates. Finally, we generated a map linking transcriptional control to 
metabolic flux through the central carbon metabolic pathway and highlighted several regulators 
critical for future metabolic engineering efforts. 
Taken together, these chapters represent the first thorough examination, systematic 
application, and quantitative evaluation of the utilization of network models for predicting 
unobserved expression and phenotype state and guiding biological research. In this work we 
advance the network biology field by utilizing the predictive power of networks, rather than 
focusing on network structural accuracy. We believe that in the future quantitative novel 
genotype expression prediction will become viable with improvements in the accuracy and 
perturbation simulation of direct and functional regulatory models. In addition, we believe that 
many more datasets will assay cellular state in multiple dimensions and phenotypes, allowing for 
more complete cellular modeling and engineering. We are on the cusp of fulfilling the promise of 
Systems Biology to allow for prediction and manipulation of cellular behavior. 
5.2 Future Directions 
Chapter 2 presents a method to improve causative network model inference and de novo 
inference of TF binding specificity models by integrating the two tasks. Although this approach 
was successfully demonstrated, there are several limitations that could be improved with 
additional research effort. Currently, a relatively simple method for calculating the binding 
potential score is scanning a PWM over a promoter sequence and adding the significant hits. 
However, adopting a more biologically motivated strategy would allow for the computed binding 
potential to better reflect the observed binding in ChIP experiments. DNA sequence conservation 
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is a strong predictor of TF binding sites that could be included in the binding potential scoring by 
up-weighting significant PWM hits that occur in conserved regions of DNA (Stormo 2013). In 
addition, experimentally validated binding of TFs has been observed to cluster around 
transcription start sites. Therefore, a weighting based on the distance of the PWM hit from the 
transcription start site could also improve the binding potential scoring scheme (Ouyang et al. 
2009). 
Besides strengthening the scoring scheme used to construct the physical network model, 
future work will likely improve on the methods used to combine the functional and physical 
transcriptional network models. In Chapter 2, the score assigned to each interaction in the 
combined model is the geometric mean of the interaction scores in the expression based 
functional model and binding based physical model. Unlike arithmetic mean, the geometric mean 
function requires interactions to be support by both binding and expression evidence in order to 
be high scoring. However, the geometric mean function does not allow for the consideration of 
interactions between the functional and physical evidence, which could boost the confidence in 
the existence of an interaction. If for example, we observe an enrichment of physical binding 
support for interactions in which a TF is predicted to activate its targets, then we may infer that 
the TF is an activator, and boost the score of activating interactions. Unfortunately, due to the 
lack of trustworthy labeled data, it is difficult to synthesize functional and physical regulatory 
models into a single causative model by applying supervised machine learning methods. There is 
a rich literature of unsupervised and semi-supervised methods that should be investigated, such 
as rank aggregation and co-training. In addition to generating better functional and physical 
combined models, improving and standardizing methods to integrate a variety of interaction 
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evidence into a single network model will become more important as more types of interaction 
features, like chromatin marks, become widely available. 
In Chapter 3, we integrated the often separated processes of computational modeling and 
experimentation. We did this by selecting the next set of TF deletion and expression profile 
experiments using a novel method, PhenoProphet, which assigns a score to each TF based on the 
confidence that the TF regulates a phenotype of interest. Although this method worked well, 
there is a high time and monetary cost associated with generating a TF deletion strain and 
expression profiling the strain. Therefore the PhenoProphet method could be improved by adding 
a complete cost benefit analysis to the scoring of TFs. An improved PhenoProphet should 
consider the novelty of the TF-phenotype relationship, the knowledge base of the sub-network 
the TF resides in, the cost associated with generating the deletion, and the amount of deletions 
that can be generated in total.  
Our focus in Chapter 3 is on identifying the key transcription factors that regulate capsule 
induction. However, we can also use the network to identify the non-regulator end-effector genes 
that encode the enzymes and transporters necessary for capsule synthesis. In preliminary 
investigations, we trained a random forest model to classify genes as capsule synthesis end-
effectors based on their regulation patterns. This machine learning approach was promising, but 
investigation of other machine learning classifiers, and the inclusion of additional predictive 
features, such as temporal expression patterns, could improve classification accuracy.  
Conservation is an important sign of functionality in DNA sequence analysis. In recent 
years, with the increased availability of expression profiles and network inference methods, 
transcriptional regulatory networks have been inferred for many well-studied organisms. 
Although transcriptional networks exist for many organisms, these networks are rarely compared 
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to identify conserved interactions among orthologous genes. A promising area of future work is 
multi-species network conservation and alignment. One potential benefit of network 
conservation research is strengthening network structural accuracy by modifying the confidence 
in each inferred interaction based on the level of conservation of the interaction. In addition, 
networks could be aligned and those alignments could then be compared to identify important 
similarities and differences related to organism phenotype similarities and differences. Currently 
it is possible to apply these principles of network conservation to better infer and understand the 
regulatory network controlling capsule induction in Cryptococcus neoformans. In Gene 
Expression Omnibus there are at least 100 expression profiles of five fungi, including the 
Ascomycota phylum fungi Saccharomyces cerevisiae, Schizosaccharomyces pombe, and 
Candida albicans, and the Basidiomycota phylum fungi Cryptococcus neoformans and Ustilago 
maydis (Barrett et al. 2013). Transcriptional networks could be inferred for each of the five 
fungi, and the network of Cryptococcus neoformans could be modified based on interaction 
conservation. In addition, non-conserved interactions unique to Cryptococcus neoformans could 
be studied in depth due to their potential importance for cryptococcal specific virulence.  
In addition to using the network to guide experimentation, in Chapter 3, we also overlay 
temporal expression patterns on the network hierarchy to generate an initial model of the 
dynamics of cryptococcal capsule regulation. However, to truly understand the dynamics of 
capsule regulation, we must observe the cryptococcal expression state over the course of capsule 
induction and in a variety of different host-like conditions. With expression profiles in a variety 
of partial and complete capsule inducing conditions, the conditions and molecular responses 
required to generate capsule could be identified. Also, with large-scale expression profiling over 
multiple time-points of capsule induction, the transcriptional network models specific to each 
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time-point could be inferred and the time-course of specific processes required to generate 
capsule could be understood.  
The ultimate goal of this thesis was to develop methods which utilized the predictive power 
of transcriptional regulatory network models to aid in experimental design and cellular 
engineering efforts. In Chapter 4 we demonstrated that transcriptional network models are 
capable of making accurate qualitative predictions of the gene expression and physiological 
phenotype state in novel genotypes, which can be used to guide future research. However, the 
accuracy of quantitative predictions necessary to truly understand and manipulate cellular 
decision making is still lacking with current network models.  
In uncompleted research work, we have developed a workflow for generating accurate 
quantitative phenotype predictions for an organism in a novel genotype. We have proposed to 
first generate a causative network model by integrating direct and functional evidence using the 
methods presented in Chapter 2. Then we would simulate the novel genotype using the causative 
network’s underlying parameterized mathematical model to generate the predicted expression 
state. Next, we would take the intersection of two rounds of feature selection to limit the set of 
explanatory genes used to predict the physiological phenotype. In one round of feature selection, 
we would test expression prediction accuracy through cross validation on observed expression 
states, and choose only the genes whose expression can be predicted reliably by the network 
model. In the second round of feature selection, we would identify gene biomarkers of the 
phenotype as genes whose expression pattern correlates with the measured levels of the 
phenotype. After feature selection, we would use the observed gene expression profiles and 
matching phenotype levels to train a supervised machine learning model, such as a random 
forest, to link the expression state of the selected genes to physiological phenotype state. Finally, 
98 
 
we would generate the predicted phenotype level in the novel genotype by supplying the trained 
machine learning model with the predicted expression state of the selected genes in the novel 
genotype. We have attempted to apply this approach to modeling and predicting the response of 
Drosophila melanogaster to high and low sugar feeding, but several problems emerged that 
limited the accuracy of hemolymph glucose levels, fat body triacylglyceride levels (TAG) and animal 
weight phenotype predictions.  
We found that the gene expression predictions were quite noisy, resulting in only a very small 
fraction of genes passing both feature selection steps. In an effort to improve the novel genotype 
expression predictions, we have started to improve the causative network model. Previously, we have 
observed that better network models can be constructed by combining multiple network models, each 
inferred from a different expression profiling dataset[CITE HAYNES ET AL 2012]. We will improve our 
sugar response network model by combining network models inferred using 1,551 expression profiles 
from 14 large publically available Drosophila melanogaster expression datasets. In addition, we will 
integrate direct regulatory evidence, in the form of binding specificities, for an additional 72 Drosophila 
melanogaster TFs. When integrated into the causative network model, 372 of the 701 modelled 
TFs will have both direct and functional regulation evidence. Also, we will apply the methods 
discussed in Chapter 2 to discover the binding specificity of addition TFs.  
We also found that further work was required to improve the prediction of physiological 
phenotypes from gene expression predictions. Due to the expected noise of gene expression 
predictions it is necessary to utilize noise tolerant prediction methods, even after improvements 
to the causative network model. One approach to reduce the noise inherent in the independent 
variable genes used to predict phenotype would be to combine genes into pathways of genes, and 
use the expression of each pathway, summarized by the mean expression of genes within each 
pathway, as the independent variables. Another difficulty we encountered when predicting the 
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Drosophila melanogaster phenotypes was that the gene expression and phenotype states differ 
greatly between the observed high and control sugar feeding conditions. Unfortunately, neither 
sugar feeding condition had enough observations of expression and phenotype level to generate a 
sugar environment specific model. Therefore, a sugar independent model of phenotype level was 
required, but we encountered difficulties training an accurate model of both conditions. 
Specifically, due to the large differences between the sugar feeding conditions, error reduction 
during model training focused on the effect of sugar feeding, rather than the more nuanced effect 
of genotype. Further exploratory work is required to fix this issue, and viable methods may 
include normalizing the data to remove the effect of the sugar feeding condition, or utilizing 
additional feature selection to identify predictors important in both sugar feeding conditions. 
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Appendix 
Appendix Figure 1. PWM Inference and Integration Steps. 
 
The steps necessary to infer and integrate PWMs into a network model are outlined 
above. First, we utilize NetProphet to infer a gene regulatory network model from gene 
expression profiles. Then we modify the TF-target interaction scores using each TF’s regulatory 
sign and DBD homology (see 2.5.4 Improving DNA Binding Specificity Inference). FIRE is 
used to infer PWMs for each TF by identifying 7-mers that occur often in the promoter 
sequences of targets with high modified TF-target interaction scores. Good PWMs are selected 
by comparing the PWM ranking of target genes to the expression-only network ranking of target 
genes. Finally, selected PWMs are used to build a binding-based network model which is 
combined with the expression-based network model.  
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Appendix Table 1. Mutant strains generated in KN99α. 
Gene name Gene identifier Selection criterion Capsule thickness
a
 
ADA2 CNAG_01626 Correlation -15 
ARO8001 CNAG_04345 Correlation 1 
ASG1 CNAG_03849 Correlation -2 
ASG101 CNAG_03018 Other
b
 NA 
BIK1 CNAG_06352 Phenoprophet -1 
CAC1 CNAG_03202 Literature -29 
CCD3 CNAG_00732 Correlation 1 
CCD4 CNAG_03279 Correlation -1 
CCD6 CNAG_06252 Correlation 0 
CEP3 CNAG_06276 Correlation 3 
CIR1 CNAG_04864 Literature -18 
CLR1 CNAG_04353 Phenoprophet 3 
CLR2 CNAG_03378 Phenoprophet 0
c
 
CLR3 CNAG_00871 Correlation 4 
CLR4 CNAG_04908 Correlation -3 
CLR5 CNAG_05067 Correlation -3 
CLR6 CNAG_07797 Other
d
 -4 
ECM2201 CNAG_00883 Correlation -10 
FAP1 CNAG_07506 Correlation -9 
FHL1 CNAG_05535 Phenoprophet -12 
FKH101 CNAG_05861 Phenoprophet 3 
FKH2 CNAG_02566 Phenoprophet 3 
GAT201 CNAG_01551 Literature -21 
HAP2 CNAG_07435 Phenoprophet 0 
HAP3 CNAG_02215 Literature -7 
HAP5 CNAG_07680 Literature -9 
HOG1 CNAG_01523 Literature 5 
MAL13 CNAG_02774 Correlation -2 
MBS1 CNAG_07464 Phenoprophet -12 
MCM1 CNAG_07924 Other
d
 -3 
MLR1 CNAG_00031 Correlation -2 
NRG1 CNAG_05222 Literature -9 
PDR802 CNAG_03894 Phenoprophet 3 
PKR1 CNAG_00570 Literature 11 
RDS2 CNAG_03902 Correlation 0 
RIM101 CNAG_05431 Literature -16 
SSN801 CNAG_00440 Literature
e
 0
c
 
SWI6 CNAG_01438 Phenoprophet -3 
TUP1 CNAG_02153 Literature 7 
USV101 CNAG_05420 Correlation 3 
YRM103 CNAG_04093 Correlation -1 
 
a
Difference from wild type, in pixels. 
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b
ASG101 was deleted for an unrelated project; it is included here because its expression profile was included as 
input for our NetProphet network. 
c
Strains lacking CLR2 and SSN801 have normal capsule thickness but increased variance; see text. 
d
CLR6 and MCM1 were selected for deletion based on manual inspection of an early version of the network. 
e
ssn801 cells were previously reported to be hypercapsular, but we find that the distribution of capsule thicknesses 
for these cells has the same mean, but significantly increased variance, compared to wild type. 
 
Appendix Table 2.A. Capsule-implicated genes not shown in Appendix Table 1 that were used 
for PhenoProphet analysis. 
LOCUS NAME 
YEAST 
ORF 
YEAST 
NAME 
Cn Sc 
PROTEIN 
ALIGNMEN
T EVAL RATIONALE CITATION PMID 
CNAG_00
124 CAS32 YJL010C NOP9 5E-1 
Hypocapsular in 
Double 
Moyrand et al., 
2004 15590825 
CNAG_00
268 ILV2 YMR108W ILV2 0E+0 Hypocapsular 
Kingsbury et 
al.,2004 15133116 
CNAG_00
375 GCN5 YGR252W GCN5 4E-112 Hypocapsular 
O'Meara et 
al.,2010 20581290 
CNAG_00
396 PKA1 YKL166C TPK3 5E-125 Hypocapsular Hicks et al.,2004 14871933 
CNAG_00
531 ENA1 YDR039C ENA2 0E+0 Hypercapsular Jung et al., 2012 22343280 
CNAG_00
600 CAP60 YPL058C PDR12 2E+0 Hypocapsular 
Chang and Kwon-
Chung,1998; 
Moyrand and 
Janbon,2004 
9573112, 
15590833 
CNAG_00
623 EGCrP1 YIR007W YIR007W 1E-54 Hypocapsular 
Ishibashi et al 
2012 22072709 
CNAG_00
697 UGE1 YBR019C GAL10 6E-83 Hypercapsular 
Moyrand et 
al.,2007 17462022 
CNAG_00
701 CAS31 YGR004W PEX31 2E+0 
Hypocapsular in 
double 
Moyrand et al., 
2004 15590825 
CNAG_00
721 CAP59 YBR274W CHK1 1E+0 Hypocapsular 
Chang and Kwon-
Chung,1994; 
Moyrand and 
Janbon,2004 
8007987, 
15590833 
CNAG_00
746 CAS35 YHR165C PRP8 4E+0 Hypocapsular 
Moyrand et 
al.,2004; Moyrand 
et al.,2007 
15590825, 
17462022 
CNAG_00
769 PBS2 YJL128C PBS2 9E-104 Hypercapsular Bahn et al.,2005 15728721 
CNAG_00
996 PMT4 YJR143C PMT4 2E-176 Hypocapsular Willger et al.,2009 19633715 
CNAG_01
106 VPH1 YOR270C VPH1 0E+0 Hypocapsular 
Erickson et 
al.,2001 11737651 
[112] 
 
CNAG_01
156 CAP2 YNL183C NPR1 1E+0 Homology 
Moyrand et 
al.,2007 17462022 
CNAG_01
172 PBX1 YGR099W TEL2 1E+0 Hypocapsular Liu et al.,2007 17337638 
CNAG_01
371 CRG2 YOR301W RAX1 3E-10 Hypercapsular Shen et al,2008 18658258 
CNAG_01
654 CAS34 YOR377W ATF1 2E+0 GXM defect 
Moyrand et 
al.,2007 17462022 
CNAG_01
678 NHA1 YLR138W NHA1 1E-122 Hypercapsular Jung et al., 2012 22343280 
CNAG_01
727 SSA1 YER103W SSA4 0E+0 Hypercapsular Zhang et al.,2006 17040492 
CNAG_01
845 PKC1 YBL105C PKC1 2E-128 Hypocapsular Heung et al.,2005 15946943 
CNAG_01
890 MET6 YER091C MET6 0E+0 Hypocapsular Pascon et al.,2004 15347759 
CNAG_02
029 WSP1 YOR181W LAS17 1E-26 Hypocapsular Shen et al,2011 21357479 
CNAG_02
036 CAS4 YML038C YMD8 9E-5 
Hypocapsular in 
double 
Moyrand et 
al.,2007 17462022 
CNAG_02
236 PPG1 YNR032W PPG1 4E-104 Hypocapsular Gerik et al.,2005 16194228 
CNAG_02
581 CAS33 YGL173C KEM1 5E-1 
Hypocapsular in 
double 
Moyrand et al. 
2004 15590825 
CNAG_02
702 CLC-A YJR040W GEF1 3E-122 Hypocapsular 
Zhu and 
Williamson,2003 14622414 
CNAG_02
797 CPL1 YML029W USA1 1E+0 Hypocapsular Liu et al.,2008 18854164 
CNAG_02
885 CAP64 YGR191W HIP1 8E+0 Hypocapsular 
Chang et al.,1996; 
Moyrand and 
Janbon,2004 
8675296, 
15590825 
CNAG_03
120 AGS1 YGR292W MAL12 4E-5 Hypocapsular Reese et al.,2007 17244196 
CNAG_03
322 UXS1 YBR019C GAL10 1E-10 Hypocapsular 
Moyrand et 
al.,2002 12139628 
CNAG_03
426 GMT2 YGL225W VRG4 1E-89 
Hypocapsular in 
double Cottrell et al., 2007 17351078 
CNAG_03
438 HXT1 YMR011W HXT2 6E-87 Hypercapsular 
Chikamori and 
Fukushima, 2005 15907385 
CNAG_03
582 RIM20 YOR275C RIM20 8E-26 Hypocapsular 
O'Meara et 
al.,2010 20174553 
CNAG_03
644 CAS3 YPL164C MLH3 4E+0 
Hypocapsular in 
double 
Moyrand et al. 
2004 15590825 
CNAG_03
670 IRE1 YHR079C IRE1 1E-104 Hypocapsular Cheon et al. 2011 21852949 
CNAG_03
735 CAP4 YGR286C BIO2 1E-1 Homology 
Moyrand et al. 
2007 17462022 
CNAG_03
818 SSK1 YLR006C SSK1 9E-50 Hypercapsular Bahn et al,2007 17951522 
CNAG_04
312 MAN1 YER003C PMI40 2E-52 Hypocapsular Wills et al.,2001 11359567 
CNAG_04
320 CPS1 YBR023C CHS3 1E-2 Hypocapsular Chang et al.,2006 16790766 
CNAG_04 GPA1 YER020W GPA2 9E-112 Hypocapsular Alspaugh et 9389652 
[113] 
 
505 al.,1997 
CNAG_04
730 GPR4 YMR172W HOT1 2E-2 Hypocapsular Xue et al.,2006 16291861 
CNAG_04
969 UGD1 YDR109C YDR109C 6E-1 Hypocapsular 
Moyrand and 
Janbon,2004; 
Griffith et al.,2004 
15590833, 
15383535  
CNAG_05
081 PDE1 YGL248W PDE1 1E-5 Hypercapsular Hicks et al.,2005 16339715 
CNAG_05
139 UGT1 YER077C YER077C 6E-1 Hypercapsular 
Moyrand et 
al.,2007 17462022 
CNAG_05
148 CXT1 YLR288C MEC3 4E+0 GXM defect 
Moyrand et 
al.,2007; Klutts et 
al.2007 
17462022 
,17430900 
CNAG_05
218 ACA1 YNL138W SRV2 6E-75 Hypocapsular Bahn et al.,2004 15590822 
CNAG_05
254 NSTX YPL244C HUT1 6E-41 Hypocapsular 
Doering et al. 
unpublished 
 
CNAG_05
465 GIB2 YMR116C ASC1 1E-92 
overexpression 
suppresses gpa1- 
capsule defect Palmer,et al 2006 16950773 
CNAG_05
562 PBX2 YGR125W YGR125W 2E-1 Hypocapsular Liu et al.,2007 17337638 
CNAG_05
563 HOS2 YGL194C HOS2 3E-137 Hypercapsular Liu et al.,2008 18854164 
CNAG_05
581 CHS3 YBR023C CHS3 0E+0 Hypercapsular 
Baker et 
al.,2007,Banks et 
al.,2005 
17400891, 
16278457 
CNAG_05
650 UBP5 YMR304W UBP15 8E-160 Hypocapsular Fang et al.,2012 22719877 
CNAG_05
703 LRG1 YDL240W LRG1 7E-61 Hypocapsular Gerik et al.,2005 16194228 
CNAG_05
721 MFE2 YKR009C FOX2 0E+0 Hypocapsular 
Kretschmer et 
al.,2012 22707485 
CNAG_05
817 GMT1 YGL225W VRG4 2E-92 Hypocapsular Cottrell et al.,2007 17351078 
CNAG_06
016 CAP6 YIR021W MRS1 6E-1 Homology 
Moyrand et 
al.,2007 17462022 
CNAG_06
301 SCH9 YHR205W SCH9 2E-142 Hypercapsular Wang et al.,2004 15503029 
CNAG_06
591 SET302 YKR029C SET3 7E-21 Hypercapsular Liu et al.,2008 18854164 
CNAG_06
808 CPRa YKL178C STE3 2E-24 Hypocapsular Chang et al.,2003 12933837 
CNAG_06
813 CAP1 YML128C MSC1 2E+0 Homology 
Lengeler et 
al.,2002 12455690 
CNAG_07
408 STE20 YNL298W CLA4 1E-113 Hypocapsular Wang et al.,2002 12455960 
CNAG_07
470 PDE2 YOR360C PDE2 2E-21 Hypercapsular Hicks et al.,2005 16339715 
CNAG_07
554 CAP10 YOR172W YRM1 4E+0 Hypocapsular 
Chang and Kwon-
Chung,1999; 
Moyrand and 
Janbon,2004 
10482503, 
15590825 
[114] 
 
CNAG_07
636 CSR2 YBL061C SKT5 3E-73 Hypercapsular 
Baker et 
al.,2007,Banks et 
al.,2005 
17400891, 
16278457 
CNAG_07
701 CTR2 YLR411W CTR3 5E-1 Hypocapsular 
Chun and 
Madhani, 2010 20824073 
CNAG_07
718 CIN1 YIR006C PAN1 2E-33 Hypocapsular Shen et al,2010 20345666 
CNAG_07
937 CAS1 YGL139W FLC3 5E+0 
O-acetylation 
defect Janbon et al.,2001 17462022 
 
Appendix Table 2.B. Regulator genes used for methods analysis in Fig. 3.4, with closest yeast 
homolog, protein alignment Eval, TF status (DNA-binding TF or not), capsule phenotype, and 
source for the phenotype; blue shading indicates genes that were not part of our uniform deletion 
set in KN99. 
LOCUS NAME 
YEAST 
ORF 
YEAST 
NAME 
Cn Sc 
PROTEIN 
ALIGNMENT 
EVAL IS TF 
CAPSULE 
EVIDENCE SOURCE PMID 
CNAG_0
0031 MLR1 YLR014C PPR1 2E-27 TRUE Normal This study 
 CNAG_0
0156 SP1 YNL027W CRZ1 2E-23 TRUE Hypercapsular 
Adler et al, 
2011 21487010 
CNAG_0
0193 GAT1 YFL021W GAT1 2E-21 TRUE DefectInGXM 
Kmetzsch et 
al. 2011 20673806 
CNAG_0
0440 SSN801 YNL025C SSN8 5E-24 FALSE Hypervariable 
Liu et 
al.,2008; 
found to be 
hypervarible 
in this study 18854164 
CNAG_0
0570 PKR1 YIL033C BCY1 5E-61 FALSE Hypercapsular 
D'Souza et 
al.,2001 11287622 
CNAG_0
0732 CCD3 YML076C WAR1 1E-1 TRUE Normal This study 
 CNAG_0
0871 CLR3 YFL031W HAC1 2E+0 TRUE Hypercapsular This study 
 CNAG_0
0883 ECM2201 YLR228C ECM22 9E-5 TRUE Hypocapsular This study 
 CNAG_0
1242 HAPX YDR259C YAP6 3E-4 TRUE Normal 
Jung et al. 
2010 21124817 
CNAG_0
1438 SWI6 YLR182W SWI6 1E-40 TRUE Hypocapsular This study 
 CNAG_0
1454 
STE12α 
YHR084W STE12 7E-31 TRUE Hypocapsular 
Yue et al. 
1999 10581270 
CNAG_0
1523 HOG1 YLR113W HOG1 4E-172 FALSE Hypercapsular 
Bahn et 
al.,2005 15728721 
CNAG_0 GAT201 YMR136W GAT2 4E-13 TRUE Hypocapsular Liu et 18854164 
[115] 
 
1551 al.,2008 
CNAG_0
1626 ADA2 YDR448W ADA2 2E-74 TRUE Hypocapsular 
Haynes et al. 
2011 22174677 
CNAG_0
2153 TUP1 YCR084C TUP1 1E-102 FALSE Hypercapsular 
Lee et 
al,2009 19820119 
CNAG_0
2215 HAP3 YBL021C HAP3 5E-41 TRUE Hypocapsular 
Jung et. al 
2010 21124817 
CNAG_0
2435 
CWC2/ 
BWC2 YMR136W GAT2 2E-11 TRUE Normal 
Idnurm et al. 
2005; Lu et 
al. 2005 
15760278, 
15813738 
CNAG_0
2566 FKH2 YNL068C FKH2 2E-15 TRUE Hypercapsular This study 
 CNAG_0
2774 MAL13 YKL038W RGT1 6E-8 TRUE Normal This study 
 CNAG_0
3202 CAC1 YJL005W CYR1 0E+0 FALSE Hypocapsular 
Alspaugh et 
al.,2002 12455973 
CNAG_0
3279 CCD4 YDR213W UPC2 7E-7 TRUE Normal This study 
 CNAG_0
3366 ZNF2 YNL027W CRZ1 1E-14 TRUE Normal 
Lin et al. 
2010 20485569 
CNAG_0
3378 CLR2 YLR399C BDF1 1E+0 FALSE Hypervariable This study 
 CNAG_0
3409 SKN7 YHR206W SKN7 6E-30 TRUE Normal 
Coenjaerts et 
al. 2006 16696662 
CNAG_0
3849 ASG1 YIL130W ASG1 3E-18 TRUE Normal This study 
 
CNAG_0
3894 PDR802 YLR256W HAP1 4E-8 TRUE Hypercapsular 
This study; called normal 
capsular by Liu et al, 
2008 
CNAG_0
3902 RDS2 YPL133C RDS2 6E-49 TRUE Normal This study 
 CNAG_0
4093 YRM103 YLR014C PPR1 5E-7 TRUE Normal This study 
 CNAG_0
4345 ARO8001 YDR421W ARO80 6E-6 TRUE Normal This study 
 CNAG_0
4353 CLR1 YJR127C RSF2 2E-2 TRUE Hypercapsular This study 
 CNAG_0
4864 CIR1 YJL110C GZF3 8E-18 TRUE Hypocapsular 
Jung et 
al.,2006 17121456 
CNAG_0
4908 CLR4 YGR089W NNF2 9E-1 TRUE Hypocapsular This study 
 CNAG_0
5067 CLR5 YLR399C BDF1 6E-1 FALSE Hypocapsular This study 
 CNAG_0
5222 NRG1 YDR043C NRG1 2E-17 TRUE Hypocapsular 
Cramer et 
al.,2006 16835458 
CNAG_0
5392 ZAP104 YJL056C ZAP1 7E-39 TRUE Normal 
Schneider et 
al. 2012 22916306 
CNAG_0
5420 USV101 YPL230W USV1 5E-19 TRUE Hypercapsular This study 
 CNAG_0
5431 RIM101 YHL027W RIM101 5E-32 TRUE Hypocapsular 
O'Meara et 
al.,2010 20174553 
CNAG_0
5535 FHL1 YPR104C FHL1 4E-16 TRUE Hypocapsular This study 
 
[116] 
 
CNAG_0
5861 FKH101 YIL131C FKH1 2E-9 TRUE Hypercapsular This study 
 CNAG_0
6134 BZP1 YFL031W HAC1 8E-2 TRUE Normal 
Idnurm et al. 
2009 19151325 
CNAG_0
6252 CCD6 YDR213W UPC2 8E-8 TRUE Normal This study 
 CNAG_0
6276 CEP3 YMR168C CEP3 1E-6 TRUE Hypercapsular This study 
 CNAG_0
6352 BIK1 YCL029C BIK1 1E-7 FALSE Normal This study 
 CNAG_0
6762 GAT204 YMR136W GAT2 3E-6 TRUE Normal 
Chun et al. 
2011 21402362 
CNAG_0
7435 HAP2 YGL237C HAP2 2E-24 FALSE Normal This study 
 CNAG_0
7464 MBS1 YDL056W MBP1 7E-36 TRUE Hypocapsular 
Song et al, 
2012 22080454 
CNAG_0
7506 FAP1 YNL023C FAP1 8E-23 TRUE Hypocapsular This study 
 CNAG_0
7680 HAP5 YOR358W HAP5 2E-35 FALSE Hypocapsular 
Jung et 
al,2010 21124817 
CNAG_0
7797 CLR6 YKL070W YKL070W 3E-8 FALSE Hypocapsular This study 
 CNAG_0
7924 MCM1 YMR043W MCM1 6E-34 TRUE Hypocapsular This study 
  
